THERMOSTABLE XYLANASES

Abstract: The present invention discloses enzymes having xylanase activity. The xylanases are characterized in that they are active at a temperature of 80 DEG C or higher. The enzymes are obtainable from anaerobic thermophilic bacteria. The enzymes are suited for use in paper and pulp production processes. The invention also describes cloning and expression of genes having xylanase activity obtained from the deposited strains.

Description: Thermostable xylanases Technical field The present invention relates to novel microorganisms and to novel enzymes. More specifically, the enzymes are thermostable xylanases. These xylanases are obtainable from anaerobic thermophilic bacteria. The xylanases are applicable under conditions used in the paper and pulp industry i.e. a pH of above 9 and a temperature of above 70°C, specifically the enzymes are active at T = 80°C. Background of the invention Xylan is a component of plant hemicellulose. Xylan consists of a backbone of 1 ,4-glycosidically linked ?-D-xylose. Usually xylans have side chains or groups comprising xylose and other pentoses, hexoses, uronic acids and acetyl groups. In the paper production process the bleaching of pulp is an important step. Schematically, the process used for pulp treatment in the paper and pulp industry is performed as follows: Pulp is treated at pH 10-12 at 80°C to remove most of the lignin in the so- called oxygen delignification step. The remaining pulp contains 2-5% of lignin. This lignin gives the pulp its brown color. Subsequently, the pulp is bleached in a multistage bleaching process. In this bleaching process chemicals such as chlorine, chlorine dioxide, hydrogen peroxide and/or ozone are used, to obtain a bright pulp for high quality paper. Chlorine and chlorine-containing chemicals are often used in the bleaching process. However, since the use of these chemicals leads to the formation of dioxin and other chlorinated organic compounds, they form a threat to the environment. Therefore, there is a growing tendency to omit the use of chemicals giving rise to this kind of waste products. This has prompted a tendency to develop chlorine-free processes; total chlorine-free (TCF) and elementary chlorine-free (ECF). In these processes hydrogen peroxide or ozone is used for bleaching. However, the use of these oxidative chemicals may have a negative effect on the quality of the paper, especially the strength of the paper. It has been found that certain enzymes make the pulp more accessible to bleaching agents, thereby reducing the amount of bleach. Xylanases, in particular, have been found to be very useful in the paper and pulp processing. Xylanases have been reported to increase the extractability of lignins from the pulp. In current processes, xylanases are mostly used after the oxygen delignification step, because they are not active and do not survive under conditions used during oxygen delignification. Xylanases cleave the hemicellulose chains which are responsible for the close adherence of lignin to the cellulose network. After xylanase treatment the lignin is more easily removed in the subsequent steps. Therefore the use of xylanases leads to a reduction of the consumption of active chlorine in prebleaching of 25-30%. This reduction of chlorine does not afflict the quality parameters of the resulting paper (Viikari et al. 1 986. Proc. of the third Int. Conf. Biotechnology in Pulp and Paper Ind., Stockholm, p.67-69 and Bajpai and Bajpai. 1 992. Process Biochemistry. .27 : 31 9-325). The xylanase treatment also reduces the need for other chemicals, such as hydrogen peroxide, in the bleaching process. The use of xylanases from fungal sources in bleaching of kraft pulp has been reported. These are acidic xylanases and the pH and temperature optima of the enzymes are : pH = 3-5 and T = 30-50°C. These values are not ideal for the use in the bleaching process, where the prevailing conditions are pH > 9 and temperature > 70°C. Xylanases from bacterial origin, with higher pH and/or temperature optima, have been reported for use in the bleaching process. Some of these originate from the following species (pH and temperature optima of the reported xylanase activity between brackets): Bacillus pumilus (pH = 7-9, T = 40°C, Nissen et al. 1 992. Progress in Biotechnology 7 : 325-337), Bacillus stearothermophilus (pH = 7, T = 65 °C, International patent application WO 91 /10724), Dictvoglomus thermophilum (pH = 6-8, T = 70°C, European patent application EP 0 51 1 933), Rhodothermus (pH = 5.5-6.5, T = 80-100°C, European patent application EP 0 538 1 77), Thermotoqa (pH = 5-6, T = 90°C, International patent application WO 93/1 91 71 ) and Thermoanaerobacter ethanolicus (T = 68°C, Deblois and Wiegel. 1 992. Progress in Biotechnology 7 : 487-490). Although the use of some of these xylanases for bleaching has been claimed, no xylanases have been reported to date having the desired characteristics of significant delignification activity at temperature > 80°C. Summary of the invention The present invention discloses xylanases obtainable from anaerobic thermophilic microorganisms which have been isolated in pure culture from hot springs in New Zealand. The microorganisms have been deposited at the Centraal Bureau voor Schimmelcultures (CBS), Baarn, the Netherlands, on April 14, 1 994. The present invention also discloses enzymes having substantial xylanase activity at a temperature of at least 80°C. Furthermore, the present invention discloses that said xylanases possess significant delignification activity at a temperature of at least 80°C. Said enzymes are obtainable from the deposited strains. The present invention further describes a process for the preparation of the xylanases which are active at a temperature of 80°C. The process comprises cultivation of the deposited microorganisms of the present invention in a suitable medium, followed by recovery of the enzymes having the indicated activity. The present invention also discloses the cloning of the genes encoding the subject xylanases. Expression of these genes in a host cell is also disclosed. The enzymes are essentially pure when obtained in this manner. Thus the present invention also discloses another method for obtaining the xylanases, i.e. expression of recombinant DNA. The present invention further describes the application of the xylanases under conditions equivalent to industrial application conditions, using high temperature and high pH. Brief description of the figures Figure 1 : Phyiogenetic analysis of the internal consensus sequences of the six extremophilic strains. Sequences are named as followed; organism/forward primer/recombinant number. The branch number displayed are the values obtained from a boot-strap analysis of the sequences. Figure 2: Sequence alignment of family G internal consensus sequences. Figure 3: The xylanase domain of xynD from TG456 inserted as a Sphl-BamHI fragment in pJLA602. Figure 4: Paper properties of paper prepared from hardwood pulp TCF bleached as described in Example 1 5. Ref = no enzyme, 71 5 = TG456 xynD, 71 6 = Tg53 xynD. Tensile index (A), porosity (B), tear (C) and burst (D) in relation to Schoppen-Riegler values are given. Figure 5: Paper properties of paper prepared from hardwood pulp ECF bleached as described in Example 1 5. Ref = no enzyme, 71 5 = TG456 xynD, 71 6 = Tg53 xynD. Tensile index (A), porosity (B), tear (C) and burst (D) in relation to Schoppen-Riegler values are given. Figure 6: Paper properties of paper prepared from softwood pulp TCF bleached as described in Example 1 5. Ref = no enzyme, 71 5 = TG456 xynD, 71 6 = Tg53 xynD. Tensile index (A), porosity (B), tear (C) and burst (D) in relation to Schoppen-Riegler values are given. Figure 7: Paper properties of paper prepared from softwood pulp ECF bleached as described in Example 1 5. Ref = no enzyme, 71 5 = TG456 xynD, 71 6 = Tg53 xynD. Tensile index (A), porosity (B), tear (C) and burst (D) in relation to Schoppen-Riegler values are given. Figure 8: Refining curves as determined in Example 1 5 for TCF (A) and ECF (B) bleached hardwood pulp and for TCF (C) and ECF (D) bleached softwood pulp. Ref = no enzyme, 71 5 = TG456 xynD, 71 6 = Tg53 xynD. Figure 9: A comparison of the pH optima (A) and temperature optima (B) of the TG456 xynD xylanase and Pulpzyme HB (Novo Nordisk). Figure 10: A comparison of the thermostabilities of the TG456 xynD xylanase and Puipzyme HB (Novo Nordisk) at 80°C, pH 7.0 (A) and at 65 °C, pH 9.0 (B). Detailed description of the invention The present invention discloses microorganisms which have been isolated from hot springs in New Zealand. These microorganisms have been characterized as anaerobic thermophilic bacteria and have been classified according to Rainey (1 992. PhD thesis, University of Waikato, Hamilton, New Zealand). The microorganisms have subsequently been screened using a xylan- agar diffusion assay. Strains which showed a clearing zone in this test were selected as potential xylanase producing strains. The strains were grown under anaerobic conditions at pH 7.0 and T = 75 or 80°C depending on the organism. After concentration by ultrafiltration, the culture broth was analyzed for xylanase activity in an assay at pH = 6.5 and 9 and T = 80°C (Example 1 ) . Six different strains were found to produce xylanase activity under the indicated conditions. These microorganisms have been deposited at the CBS on April 14, 1 994 under deposition numbers: CBS 21 1 .94, CBS 212.94, CBS 21 3.94, CBS 214.94, CBS 21 5.94 and CBS 21 6.94. The present invention also discloses enzymes having xylanase activity, specifically enzymes having at least a considerable xylanase activity at a temperature of at least 80°C and a pH of 6 or higher. Said enzymes are obtainable from the deposited strains. Said enzymes are also obtainable from mutants and variants of the deposited strains. With the expression "considerable activity" is meant that the enzymes of the present invention have at least 80°C, at least 40% of the activity they possess at 70°C, preferably this is at least 60%, more preferably about at least 80%, even more preferably about 200%. The present invention further describes a process for the preparation of the xylanases which are active at a temperature of about 80°C or having a considerable activity under these conditions. The process comprises cultivation of the deposited microorganisms of the present invention in a suitable medium, followed by recovery of the enzymes having the indicated activity. Isolation and purification of the xylanase can be performed using standard procedures known in the art. A partial purification of the enzymes is exemplified in Example 2. In this example the cells are first removed by hollow fibre filtration. Subse- I quently, the protein is further purified by ammonium sulphate addition to a final concentration of 1 M. The solution is then brought on a phenyl sepharose column and the protein eluted with 1 M NaCI. Finally, the protein is concen¬ trated by ultrafiltration and salt is removed by diafiltration. To establish the xylan degrading potential of the xylanases at an alkaline pH, a comparison of the activities of the xylanases isolated from the indicated strains at a pH of 7 and 9 has been made using different substrates and a temperature of 70°C (Example 3). The xylanases have been shown to possess considerable activity at alkaline pH. Depending on the substrate and the assay, at pH 9 the xylanases have about 20% or more of the activity they possess at pH 7. One xylanase was shown to retain 80% of its pH 7 activity at pH 9. The thermostability of the xylanases isolated from the indicated strains varies considerably. Some of the xylanases are very thermostable: they have a half-life of more than 2 hours at pH = 9 and at 80°C (see Example 4). The half-life at pH = 9.0 and 80°C of the xylanases of the invention is at least 10 minutes, preferably the half-life under these conditions is more than 20 minutes, more preferably it is more than 30 minutes, still more preferably it is more than 60 minutes and most preferably the half-life is more than 1 20 minutes. The present invention also discloses the cloning and expression of a DNA sequence characterized in that it encodes a xylanase obtainable from an anaerobic thermophilic strain. The invention discloses vectors, which include expression vectors, characterized in that they contain the DNA sequence encoding the xylanases of the present invention. A microbial host cell characterized in that it is transformed with one of these vectors is also disclosed. Sequence analysis of the DNA sequences encoding the xylanases of the invention revealed that the obtained sequences fall into two groups of enzymes families, i.e. the F-type and G-type xylanases as previously defined by Gilkes et al. ( 1 991 , Microbiol. Rev. 5_5_: 303-31 5) . The xynA, xynB and xynC sequences obtained from the microorganisms of the invention belong to the F-type xylanases; the xynD sequences obtained from these microorganisms belong to the G-type xylanases (see examples 6,7,8 and 9). G-type xylanases from thermophilic microorganisms have not been described previously to the best of our knowledge. The thermophilic microorganisms which are the source of the xylanases of the invention are herein defined as microorganisms with an optimum growth temperature which is higher than 65 °C. Preferably the optimum growth temperature is higher than 68°C, more preferably the optimum growth temperature is higher than 70°C, and most preferably the optimum growth temperature is in excess of 75 °C. Expression of the both F-type and G-type xylanase DNA sequences of the invention in E.coli is shown to give an active proteins (see Example 1 0 and 1 1 ). Said proteins are active at a temperature of 80°C. The cloning and expression demonstrated in the examples of the present description makes possible expression of the genes in homologous organisms. Expression can also be performed in other microorganism using suitable expression and secretion regulating sequences. Organisms of choice are yeast, fungi and bacteria. Specific micro-organisms include strains selected from Asperqillus niqer, Kluvveromvces lactis and Bacillus licheniformis. The enzymes of the present invention have been shown to possess a considerable activity on oat spelts xylan and on birchwood xylan. The enzymes of the present invention have further been tested for their bleaching capacity. This bleaching capacity is determined by the delignifying activity of the enzymes of the present invention. The invention discloses enzymes which have a significant delignifying activity, as measured on several wood pulps. The enzyme preparations, xylanases, are capable of delignifying wood pulp at a temperature of at least 80°C. The expression "wood pulp" is to be interpreted broadly and is intended to comprise all kinds of lignocellulosic materials. The enzymes have been tested for their bleaching capacity on both hardwood and softwood pulps. Lignin removal has been measured according to two different methods (Example 5). Lignin in the medium was determined by the A300 test. In this test all preparations showed significant delignifying activity at 80°C on both hard- and softwood. At pH 9 and 80°C the activity on softwood was at least 43% of the activity at pH 6, while on hardwood 3 strains showed at pH 9 activities of more than 50% as compared to pH 6, and 3 others 1 8-30%. Bleaching of softwood pulp was also measured by determining the decrease in the lignin content of the pulp using the kappa test. The kappa number was decreased 0.5 to 1 .4 units after incubation of the pulp at pH 9 and 80°C with the xylanase preparations. Additionally, the bleaching capacity of the enzymes of the present invention can be measured by e.g. the increase of ISO brightness of paper produced with conventionally treated pulp, additionally incubated with said enzymes, as compared to incubation without enzymes. Said conventional treatment comprises exposition to bleaching agents such as H 2 0 2 , ozone, Cl 2 or CI0 2 , according to the art. The cloned F-type and G-type xylanases of the invention as expressed in E.coli have also been tested for their performance in ECF bleaching experiments on both softwood and hardwood pulp (see Example 1 2) . Surprisingly, we have observed that the G-type xylanases (encoded by the xynD genes) show a much better performance in bleaching sequences on both softwood and hardwood pulp as compared to the F-type xylanases, up to 6.8 %IS0 delta brightness over the no-enzyme control, which compares to at most 1 .2 % ISO brightness increase for the best F-type xylanase. Further testing of the thermostable G-type xylanases showed that they also produce excellent results in TCF bleaching experiments on both softwood and hardwood pulp (see Examples 1 4 and 1 5). Verification of the properties of the paper produced from the thus bleached pulp showed no significant differences with the no-enzyme control paper. The cloned G-type xylanases are highly thermostable, even at high pH. A half-life at 80°C and pH 7.0 of more than 30 minutes was measured. At 65 °C and pH 9.0 the half-life of the enzyme is not significantly reduced, even after 1 20 minutes of incubation (see Example 1 6) . The half-life at pH 9.0 and 65 °C of the G-type xylanases of the invention is at least 10 minutes, preferably the half-life under these conditions is more than 20 minutes, more preferably it is more than 30 minutes, still more preferably it is more than 60 minutes and most preferably the half-life is more than 1 20 minutes. The invention discloses DNA sequences encoding thermostable G-type xylanases the internal consensus fragment (ICF) of which shows more than 80 % identity with the ICF of SEQ ID NO 1 2. The G-type ICF is herein defined as the fragment which lies in between the sequences corresponding to SEQ ID NO 4 and SEQ ID NO 5 in SEQ ID NO 1 2 (nucieotide positions 295 to 623) . Preferably the identity with the G-type ICF is more than 87 %, more preferably the identity is more than 95 %, most preferably, the identity is more than 99 %. In a further embodiment, the invention discloses G-type xylanase sequences which share at least 70 % identity with the amino acid sequence of SEQ ID NO 1 3. Preferably this amino acid identity is more than 80 %: more preferably, the amino acid identity is more than 90 %; still more preferably the amino acid identity is more than 95 %; most preferably the amino acid identity is more than 99 %. The enzymes of the present invention can be used immediately after the oxygen delignification step in the pulp preparation process described above. As a consequence of the temperature and pH characteristics of the enzymes, extensive cooling and pH adaptation can be avoided. In another embodiment of the invention, the enzymes are used before or during the oxygen delignification step. Before this step the lignin concentration is much higher and therefore the effect of the application of the xylanase is much larger. Furthermore, applications of the enzyme preparations of the present invention are described, particularly a process in which wood pulp is treated with said enzyme preparations according to the invention. Similarly, a fluff pulp can be treated with the enzyme preparations according to the invention. The invention further relates to paper, board and fluff pulp made from a wood pulp treated with the enzyme preparations according to the invention. Example 1 Isolation of strains producing thermostable xylanase activity Xylanase-producing microorganisms were obtained from hot springs in various thermal areas of New Zealand. The strains were isolated by in situ enrichment using oat spelts xylan as substrate from hot springs having a temperature of above 70°C, and a pH between 6.0 and 8.5. Cultures of strains were obtained by further anaerobic cultivation in the laboratory on 2/1 medium plus xylan at a temperature (70°, 75 ° or 85 °C) corresponding to the temperature of the site from which the sample was taken. The composition of the 2/1 medium plus xylan is as follows: Anaerobic 2/1 medium Resazurin (0.1 %) 1 .0 ml/I SL10 Trace Elements 1 .0 ml/I FeCI 3 soln. (0.28 mg/ml) 1 .0 ml/l Wolin's Vitamins 0.1 ml/l NaCI 0.9 g/l MgCI 2 .6H 2 0 0.2 g/l K 2 HP0 4 1 .5 g/l KH 2 P0 4 0.75 g/l NH 4 CI 0.9 g/l Cysteine 0.75 g/l Yeast Extract 0.5 g/l Bacto Tryptone 1 .0 g/l Oat spelts xylan 2 g/l pH 7.0 Dispense under N 2 gas Wolin's Vitamin Mixture mg/100ml Biotin 2.0 Folic acid 2.0 Pyridoxine HCI 10.0 Riboflavin 5.0 Thiamine 5.0 Nicotinic acid 5.0 Pantothenic acid 5.0 Vitamin B1 2 0.1 p-Aminobenzoic acid 5.0 Thioctic acid 5.0 SL10 Trace Elements, modified 5M HCL 1 5ml mg/l ZnCI 2 70 MnCI 2 .4H 2 0 100 H 3 BO 3 6 CoCI 2 .6H 2 0 1 30 CuCI 2 .2H 2 0 2 NiCI 2 . 2H 2 0 24 NaMo0 4 .2H 2 0 36 Pure cultures of strains were obtained from single colonies in agar roll tubes. Culture concentrates obtained by ultrafiltration were tested for xylanase activity at 70° and 80°C and, at pH 6.5 and 9.0 using a dyed xylan method (see below) and the PAHBAH method (see Example 3). Six strains which were deposited at the CBS (Centraal Bureau voor Schimmelcultures) are depicted in Table 1 . Table 1 : deposition numbers of strains used in this patent application strain CBS accession number TG 53 CBS 21 1 .94 TG 453 CBS 21 2.94 TG 456 CBS 21 3.94 TG 457 CBS 214.94 TG 479 CBS 21 5.94 TG 631 CBS 21 6.94 Dyed xylan, composed of larchwood xylan coupled to Remazol Brilliant Blue R (Sigma) , was prepared following a method described by Biely et al ( 1 985) Anal. Biochem 144, 142-146. Larchwood xylan (6.7 g) was placed into 250 ml water and stirred for several hours at room temperature to dissolve. Remazol Brilliant Blue R ( 10.0 g) was added to this mixture. After dissolving, 20 ml of a Na-acetate solution (2.7 g Na-acetate in 20 ml distilled water) was added dropwise. Then a solution of 6 g NaOH in 70 ml water was added and stirring continued for 1 8 hours. The dyed xylan which had formed was precipitated by the addition of 700 ml 96% ethanol. After allowing to stand for 6 hours the precipitate was separated by filtration (Whatman GF/A) . The filter cake was washed with 3 I of a 2: 1 mixture of 96% ethanol/0.05 M Na-acetate, followed by 1 I 96% ethanol and 3 I acetone until the filtrate was colourless. The yield was 10.5 g dyed xylan. For the enzyme assay, 5.1 g dyed xylan was dissolved in 1 50 ml 0.1 M MOPS buffer, pH 6.8. The mixture was stirred at 70°C for 4 hours to dissolve. After cooling to room temperature insoluble material was removed by centrifugation at 10,000 x g. For activity assays, the stock solution containing 3.34 % w/v dyed xylan was diluted with 0.1 M MOPS buffer, pH 6.8 to give a 0.5 % dyed xylan working solution. The enzyme assay using dyed xylan was performed by adding 0.9 ml dyed xylan solution (0.5%) to 0.6 ml enzyme preparation in an appropriate buffer with mixing. A portion (0.4 ml) of this mixture was transferred into 0.8 ml 96% ethanol as control (blank). The remaining solution was incubated at 70°C for 90 minutes. The reaction was terminated by transferring 0.4 ml of the test mixture into 0.8 ml 96 % ethanol. This solution was left at room temperature for 30 minutes to allow for the precipitation of uncleaved dyed xylan. The test samples were centrifuged at for 5 minutes at full speed in a Beckman Microfuge E, and the absorbance of the supernatant was measured at 595 nm in a spectrophotometer. Example 2 Isolation of enzyme preparations Anaerobic fermentations were carried out in 2 I Schott bottles containing 1 800 ml of 2/1 plus xylan medium in stationary incubation at a temperature of either 75 or 80°C (depending on the organism being cultured) for 24 hrs. From 1 0 I of well-grown culture the cells were removed by hollow fibre filtration in the presence of 0.01 % triton X100 (Amicon DC 1 0 LA and Amicon 0.1 H5MP01 -43 filter). Ammonium sulphate was added to the cell free culture medium to a final concentration of 1 M. The resulting solution was pumped onto a 9 x 1 5 cm column containing 1 I of phenyl sepharose (Pharmacia-Fast Flow-low substitution) equilibrated with 1 M ammonium sulphate. The flow rate was 1 50 - 200 ml/minute. The column was washed with 5 I 1 M ammonium sulphate. The xylanase was eluted with 5 I 1 M NaCI. Fractions were collected in 500 - 1000 ml volumes. The xylanase activity was determined (with the PAHBAH method as described in Example 3) in the fractions and the active fractions were pooled, ultrafiltered to a small volume and diafiltered to reduce the salt concentration using an Amicon Stirred Cell (Model 2000A or 8400) with an YM2 membrane. Example 3 Characterization of xylanase activities of the partially purified enzyme preparations Analytical methods Assays for xylanase activity were performed using modified procedures of the Sumner assay (Sumner et al. 1 921 . J. Biol. Chem. 47 : 5- 9) . Alternatively xylanase activity was determined using a modified PAHBAH assay, based on a method from Lever (1 973. Biol. Med. 1 : 274-281 ). Procedure 1 Sumner assay of xylanase activity on oat spelts xylan An oat spelts xylan substrate solution is prepared as follows: 4 g oat spelts xylan is suspended in 100 ml demineralized water. The suspension is sonicated for 6 minutes (sonicator: Sonics & Materials, Vibracell type VC 250 B), incubated at 100°C for 10 min., and centrifuged for 10 min. at 1 0,000 rpm in a Sorvall RC-5B centrifuge. The supernatant is used as a substrate solution and contains about 2% oat spelts xylan. The assay is carried out as follows: A test tube is filled with 200 μ\ oat spelts xylan solution, 600 μl aliquots of enzyme preparation (Example 2) diluted in the appropriate buffer. The test tube is incubated under measuring conditions in a waterbath for 1 5 minutes. After the incubation, 7.2 ml DNS (dinitrosalicylic acid) reagent is added. The mixture is heated in a waterbath at 1 00°C for 10 minutes, whereafter the test tube is cooled on ice. The absorbance is measured at 575 nm. To eliminate the background absorbance of the enzyme samples a control experiment is executed as follows: a tube containing substrate without enzyme preparation is incubated under the same conditions as the test samples. After the 1 5 minutes incubation 7.2 ml DNS and the enzyme sample is added (in this order). One unit of xylanase (xU) activity is defined as the amount of enzyme producing 1 μmol of xylose-equivalent, measured as reducing sugar. Actual measuring conditions were pH 7.0, 9.0 and 70°C. At pH 7 a 50 mM phosphate buffer was used, and at pH 9 a 50 mN borate/KOH buffer. Table 2: relative xylanase activities on oat spelts xylan, measured at 70°C Strain Activity (%) pH 7.0 pH 9.0 TG 453 100 57 TG 456 100 39 TG 457 100 31 TG 479 100 1 9 TG 631 100 31 Procedure 2 Sumner assay of xylanase activity on Birchwood xylan Essentially the same method as described in procedure 1 is used. Instead of an oat spelts xylan solution a birchwood xylan suspension is used. A birchwood xylan substrate solution is prepared as follows: 4 g birchwood xylan is suspended in 50 ml 0.2 N NaOH and agitated until visibly dissolved. The pH of the solution is adjusted to 7.0 with glacial acetic acid, water is added to 1 00 ml and the solution is centrifuged at 10,000 rpm in a Sorvall RC-5B centrifuge. The supernatant is used as a substrate solution and con¬ tains about 3% birchwood xylan. The test conditions were pH 7 and 9 and 70°C. The results are shown in Table 3. Table 3: relative xylanase activities on birchwood xylan, measured at 70°C Strain Activity (%) pH 7.0 pH 9.0 TG 453 100 40 TG 456 100 20 TG 457 100 21 TG 479 100 1 2 TG 631 100 21 Procedure 3 PAHBAH assay of xylanase activity on oat spelts xylan The modification of the PAHBAH method (Lever, 1 973) is to the PAHBAH reagent, as follows: 0.05 M trisodium citrate, 0.1 M Na 2 S0 3 , 0.02 M CaCI 2 , 0.5 M NaOH and 0.1 M p-hydroxybenzoic acid hydrazide (PAHBAH). For the assay of the enzyme preparations 0.05 ml or 0.1 mi of enzyme preparation is mixed with 0.3 ml substrate buffer (50 mM Bis-Tris- Propane, pH as required, + 0.2% oat spelts xylan in suspension). An appropriate amount of water is added to a final volume of 0.5 ml. Incubation is usually made at 70°C for 30 min. To stop the reaction, 1 .0 ml of PAHBAH reagent is added after incubation and the samples are heated at 100°C for 6 minutes. The blanks consist of substrate buffer incubated identically to the sample to which the enzyme is added after the PAHBAH reagent. Before determination of the absorption at 420 nm, all samples are centrifuged 1 min at full speed in a Beckman Microfuge E to remove suspended xylan from the supernatant. The results are shown in Table 4. From this Table it can be concluded that at pH 9.0, 80°C all strains still have a considerable activity as compared with pH 6.0, 70°C. Table 4: relative xylanase activities on oat spelts xylan, measured with the PAHBAH assay Strain Activity (%) pH 6.0, 70°C pH 9.0, 80°C TG 53 100 57 TG 453 100 20 TG 456 100 65 TG 457 1 00 82 TG 479 100 30 TG 631 1 00 65 Example 4 Thermostabilitv of xylanase activities The half-life of the xylanase activity of the enzyme preparations was determined as follows. The enzyme preparation was diluted 1 /1 0 in 1 00 mM TAPS buffer (pH 9.0 at 80°C) and incubated at 80°C. A sample was removed at 0, 10, 20, 40, 60 and 1 20 minutes and added to 1 00 mM MOPS buffer (pH 6.0 at 70°C) on ice, to a final dilution of 1 /20 to 1 /100 as ap¬ propriate for the final assay. The samples were kept on ice until they were assayed at 70°C and pH 6.0 using the PAHBAH assay method as described in Example 3, procedure 3. The results are shown in Table 5. Table 5: thermostability of xylanase activity at pH 9.0 and 80°C, as measured with the PAHBAH assay on oat spelts xylan Strain Half-life pH 9.0, 80°C TG 53 30 minutes TG 453 60 minutes TG 456 > 1 20 minutes TG 457 > 1 20 minutes TG 479 < 1 0 minutes TG 631 < 20 minutes Example 5 Delignification activities Delignification capacity of the xylanases was determined with two different methods. Using the A300 method the amount of lignin released from the pulp after enzyme treatment is estimated. Using the kappa assay the remaining lignin content of pulp after treatment is measured. Method 1 : A300 test To measure delignification with the A300 assay enzyme preparations were incubated with soft- or hardwood pulp at a concentration of 2 PAHBAH units per g of wet pulp (about 6 PAHBAH units/g of dry pulp). Incubations were performed for 2 hours at 80°C both at pH 6.0 in MOPS buffer, and at pH 9.0 in TAPS buffer. Pulp concentration in the incubation was 0.1 g wet weight per ml. Two different types of pulp were used: Kraft softwood pulp after oxygen delignification, and Kraft hardwood pulp after oxygen delignification. Properties of these pulps are given in Table 6. Table 6: properties of the pulp types used in the delignification experiments Hardwood Softwood birch 80% spruce, 20% pine Brightness, % ISO 50.8 35.8 Kappa number 1 1 .0 1 6.7 Viscosity, dm 3 /kg 979 1 003 Calcium, ppm 1 900 2600 Copper, ppm 0.3 0.6 Iron, ppm 5.1 1 1 Magnesium, ppm 21 0 270 Manganese, ppm 25 70 The amount of lignin that was removed from the pulp was determined by measuring the absorbance of the supernatant at 300 nm, after separating the supernatant from the pulp by filtration by suction through a Whatman GF/C filter supported on a sintered glass filter. The results of the A300-test are shown in Table 7. In this assay, Delta A300 values of > 0.2 are significantly higher than background levels. Therefore, this example shows that the enzymes possess a significant delignifying activity at 80°C. Table 7: A300 delignification measured at 80°C, pH 6.0 and 9.0, on soft- and hardwood Delta A300 Strain Hardwood Softwood pH 6.0 pH 9.0 % * pH 6.0 pH 9.0 % ' TG 53 0.7 0.5 71 0.6 0.35 58 TG 453 1 .0 0.3 30 0.7 0.3 43 TG 456 1 .0 0.3 30 0.6 0.6 100 TG 457 1 .0 0.7 70 1 .0 0.5 50 TG 479 0.9 0.1 6 1 8 0.8 0.6 75 TG 631 1 .2 0.7 58 0.8 0.7 88 Percentage of the activity at pH 9 as compared to pH 6 Method 2: the Kaooa test The kappa tests were performed according to TAPPI protocol T236 (available from TAPPI, Technology Park, Atlanta, USA), with some modifications. The enzyme preparation was added at a dose of 10 xU/g pulp (dry weight), and incubated for 2 hours at pH 9, 80°C. As a control pulp was incubated for the same period under the same conditions without enzyme addition. Oxygen delignified softwood pulp was used, for properties see Table 6. The difference between the kappanumber with enzyme addition and the kappanumber without enzyme addition is called the kappa reduction, and is a value for delignification. The kappa reductions are shown in Table 8. In this assay, values of > 0.5 are significantly higher than background levels. Therefore, as in the previous example, this example shows that the enzymes possess a significant delignifying activity at 80°C. Table 8: delignification as measured by kappa reduction, determined on softwood pulp, pH 9 and 80°C Strain Kappa reduction TG 453 1 .0 TG 456 1 .3 TG 457 1 .4 TG 479 1 .0 TG 631 0.5 Example 6 Cloning and sequence determination of internal consensus fragments of genes encoding thermostable F-type xylanases 6.1 . PCR amplification of internal fragments of xylanase genes Three PCR primers were used to amplify internal consensus fragments of xylanase genes: two different forward primers (xynFA, {5' CAC ACK CTK GTK TGG CA 3', SEQ ID NO 1 } and xynFB {5' CAT ACK TTK GTT TGG CA 3', SEQ ID NO 2) and one reverse primer (xynR {TMG TTK ACM ACR TCC CA, SEQ ID NO 3}) . The xynFA and xynFB primers bound at the same location, but differed slightly in sequence due to slight differences in the sequence of xylanase genes at the forward consensus region. PCR conditions were as follows: (94°C 1 minute, 50°C 1 minute, 72°C 1 minute) x 30. All family F internal consensus fragments were approximately 350bp. 6.2. Seguence determination of the PCR products All internal xylanase PCR-products (ca. 350bp) were end-repaired (back-filled) as described below prior to cloning into the Smal (phosphatased) site of the M 1 3mp1 0 sequencing vector. Step 1 - Ammonium acetate precipitation: (a) make up 50μl PCR mixture to 1 00μl with TE buffer ( 10mM Tris-CI, 1 mM EDTA, pH 8.0) . (b) add 100 /I 4M CH 3 COO-NH 4 + and 250μl 100% CH 3 CH 2 OH. (c) incubate on ice for 1 5 minutes (or overnight at -20°C). (d) centrifuge at 1 6 OOOrpm for 1 5 minutes and discard supernatant, (e) wash pellet in 500μl cold 70% CH 3 CH 2 OH. Re-centrifuge (16 OOOrpm 5') and discard supernatant, (f) dry pellet under vacuum for 5 minutes and resuspend in 20μl TE buffer. Step 2 - End-repair of PCR fragments: (a) to 20μl of precipitated DNA add: 3μl 10x Ligase buffer (Boehringer Mannheim), 1μl 1 2.5mM dNTP's (Pharmacia DNA polymerisation mixture), 0.5μl (5U) E. coli DNA polymerase large (Klenow) fragment (BRL technologies Ltd), 0.25μl (2.5U) T4 DNA polymerase (Boehringer Mannheim), 0.25μl (2.5U) T4 polynucleotide kinase (Boehringer Mannheim) and H 2 0 up to 30μl. (b) incubate at 37 °C for 30 minutes and heat-kill enzymes by incubating at 70°C for 1 0 minutes. Step 3 - Gel-purification of the end-repaired xylanase fragment: (a) run DNA through 2% LMP agarose in 1 x Tris-acetate buffer (pH 7.8). (b) excise the 350bp xylanase band from the agarose. (c) purify the DNA from the agarose slice using the GeneClean ® ) procedure (Bio1 01 Inc.). Step 4 - Ligation into M 1 3mp1 0 (Smal-phosphatased): (a) mix 1μl M 1 3mp1 0 vector DNA (appropriately diluted to ca. 10ng/μl), 20-50ng insert DNA (xylanase consensus primer fragment), 1μl 10x ligase buffer (Boehringer Mannheim), 1μl T4 DNA ligase (Boehringer Mannheim), and H20 up to 10μl. (b) incubate overnight at room temperature. Step 5 - Transformation of ligation mixture into Escherichia coli strain JM 101 : (a) transform JM 101 with the entire 10μl ligation mixture using the DMSO-mediated transformation technique of Chung et al. ( 1 989. Proc. Natl. Acad. Sci. 86: 2172-2175.). (b) Plate the M13/JM101 , and isolate recombinant M 1 3 plasmids using standard procedures (Sambrook et al. 1 989. Cold Spring Harbour Laboratory Press) . Recombinant M1 3 phage containing internal xylanase consensus fragments were sequenced from ssDNA (Sambrook et al. 1 989) on an Applied Biosystems 373A automated DNA sequencer using dye-primer chemistry (sequencing primer used was the universal M 1 3 forward {dye-labelled} primer, ABI Ltd) . All DNA sequence data were analysed and manipulated using the G C G sequence analysis software (installed on Irix) run on a Silicon Graphics Personal Iris Workstation. Family F xylanase internal fragment seguence results: Based on the PCR fragments which were amplified from the six strains depicted in Table 1 using the xylanase consensus primers, it was predicted that each organism contained between 1 to 3 family F xylanase genes. The results have been analysed via the well known boot-strap analysis (Wisconsin Molecular Biology Package, Devereux, 1984, Nucleic Acids Res. 1 2, 387- 394) . In Figure 1 a dendogram of the various xylanases and strains is shown. From the nucieotide sequences of the family F consensus fragments, it now appears that each organism will contain three different family F genes. Each of the family F xylanase genes of each organism belongs to a separate xylanase cluster (based on nucieotide and primary amino acid sequence homologies), now designated as cluster A, cluster B and cluster C. The full-length xylanase amplified from TG 456 belongs to cluster A, and has subsequently been named TG 456 xynA. In addition, an internal consensus fragments from a TG 456 cluster B xylanase (TG 456 xynB) and a cluster C xylanase (TG 456 xynC) have been identified. Example 7 Cloning and sequence determination of internal consensus fragments of genes encoding thermostable G-type xylanases 7.1 PCR amplification of internal fragments of G-type xylanase genes The Family G internal consensus fragments (lCFs) were isolated with the Polymerase Chain Reaction (PCR), using the forward and reverse family G consensus primers (GF and GR). The PCR profile was as follows: n.b. °C refers to degrees ceisius. x refers to the number of cycles (i.e. x1 equals ONE cycle) (94°C, 4 minutes) x 1 (94°C, 1 minute; 45°C, 1 minute; 72°C, 1 minute) x 35 (94°C, 1 minute; 45 °C, 1 minute; 72°C, 6 minute) x 1 The PCRs were performed in 50uL reactions using the following ingredients: 1 00ng GF primer; 1 00ng GR primer; 0.25mM dNTPs; 1 Unit Taq Polymerase; 0.25 mM MgCI2; 10mM Tris-HCI, pH 8.8; 50mM KCI; 0.001 % Gelatin; 1 -10 ng template DNA. Two PCR primers were used to amplify consensus fragments of xylanase genes: GF: TATNTGRSTNTMTATGGWTGG (forward internal consensus primer) SEQ ID NO 4. GR: CCGCTNCTTTGGTANCCTTC (reverse internal consensus primer) SEQ ID NO 5. With all six strains a PCR fragment was found upon amplification with the consensus primers. Two species of PCR-products (DNA fragments) were amplified: a 300bp fragment of the expected size, plus an unexpected 600bp PCR-product - this 600bp fragment was a head-to-tail dimer of the 300bp PCR-product; presumably this 600bp species was a result of self-priming during the PCR reactions, as a consequence of homology between the GF and GR primers. 7.2 Seguence determination of the PCR products The 300bp fragments amplified from each organism were end-repaired (see example 6). The end-repaired fragments were then purified from a 1 % low melting temperature agarose gel (run in Tris-acetate running buffer) using the Geneclean (Bio 101 , La Jolla, Calif.) procedure. Approximately 10ng of the end-repaired and gel-purified 300 ICFs were ligated into the Smal site of M 1 3mp1 0 using BM T4 DNA ligase, in 10uL reactions. 7.3 Seguence determination of the PCR products Six independent phages originating from strains TG457 and TG53 were sequenced. It appears from the alignments (Figure 2) that only a single G-type xylanase gene is present in each of these strains. In addition M 1 3mp10 recombinants containing family G ICFs from TG453, TG456, TG479 and TG631 were sequenced. These organisms contained all a family G xylanase gene encoding an essentially identical xylanase, although variations in the DNA sequence are up to 1 3 %. Example 8 Seguence of full-length F-type xylanases On the basis of the internal PCR fragments 3 different type of F- xylanase genes have been identified: xynA, xynB and xynC. Using Genome Walking PCR (GWPRCR) full length xylanase genes have been isolated from most of the strains. Full length sequences of the TG456 xynA gene have been determined. The complete sequence of the xynA gene is given in SEQ ID NO 6. The encoded amino acid sequence of the TG456 xylanase A is provided in SEQ ID NO 7. For xynB and xynC it was discovered that the genes encode multi- domain enzymes, with one xylanase domain. These xylanase domains have been subcioned using PCR primers designed on sequences at the border of the xylanase domain. The partial sequence information for the xynB and xynC genes originating from TG456 are given in SEQ ID NO 8 and SEQ ID NO 1 0, respectively. The encoded amino acid sequences of the TG456 xylanases B and C are given in SEQ ID NO 9 and SEQ ID NO 1 1 , respectively. Example 9 Complete seguence of G-type xylanase genes Using Genome Walking PCR (GWPRCR) the full length xynD genes have been isolated from most of the strains. The complete sequence for the xynD gene of TG456 is given in SEQ ID NO 1 2 and the encoded TG456 xylanase D amino acid sequence is provided in SEQ ID NO 1 3. Example 10 Construction of expression vectors and hosts for xylanase production from cloned genes In the consensus PCR primers appropriate restriction sites have been designed, which allow the subcloning of xylanase genes in suitable expression vectors. The xynA and xynC genes are inserted Ncol-BamHI into the pJLA602 expression vector [Schauder, B., Blucker, H., Frank, R., and McCarthy, J. E. G. ( 1 987). Inducible Expression Vectors Incorporating the Escherichia coli atpE Transcriptionai Initiation Region. Gene 52: 279-283.]) for in-frame fusion with the lambda L and R promoters [Gibbs, M.G, Saul D. J, Luthi, E., and Bergquist, P.L. (1 992). The beta-mannanase from "Caldocellum saccha- rolyticum" is Part of a Multidomain Enzyme. Appl. Environ. Microbiol. 58 ( 1 2): 3864-3867.] XynB and xynD genes were inserted into the unique Sphl-BamHI sites of pJLA602. Constructs were transferred into the hosts E.coli JM 101 and E.coli DH5σ using standard transformation techniques. Figure 3 shows the sequence of the xylanase domain of xynD from TG456 inserted in pJLA602 as a Sphl-BamHI fragment. Example 1 1 Production and recovery of cloned xylanases In order to obtain protein samples from the cloned F-type xylanases the E.coli clones were fermented in a 1 0.0 litre capacity LH fermenter (series 210) . The culture was maintained at 30°C until induction (42°C) with continuous aeration (4.8 litres/min), agitation (500 rpm) and pH control (pH 7.1 ) . The media used and other additions are given below: Luria Broth (for inoculum cultures): Tryptone 10 g Yeast Extract 5 g NaCI 10 g Water to 1000 m BGM2 bulk growth medium for fermenter runs (quantities are for final medium, i.e. 2 batches of 8.5 litres): NH 4 CI 3.22 g KH 2 P0 4 1 .05 g MgS0 4 .7H 2 0 0.135 g K 2 S0 4 0.043 g FeS0 4 .7H 2 0 0.003 g SL-1 0 Trace Elements 1 ml Tryptone 10 g Yeast Extract 4.7 g Glycerol 34 ml Water to 1000 ml After the fermenter vessel, with approximately 6 litres of water in it, was sterilized by autoclaving at 121 °C for 30 miniutes, it was cooled to 30°C. The media concentrate (8.5 fold concentrate) was pumped through a sterile 0.2 μm cartridge filter (Sartorius). Prior to inoculation the following additions were made: Antifoam (Bevaloid 5901 ) 10 ml (autoclaved) CaCI 2 ( 1 7 mg/ml stock) 1 ml (autoclaved) Ampicillin 850 mg (filter sterilized) Thiamine (JM101 cultures only) 8.7 mg (filter sterilized) The liquid volume was then adjusted to 8.5 litres. The pH of the media was adjusted to 7.1 . Filter-sterilized air was sparged through the fermenter at a flow rate of 4.8 litres per minute. The fermenter temperature was held at 30°C by hot and cold water circulation through finger probes. pH control was by addition of autoclaved NaOH (5M) or H 4 S0 4 (2M) . The fermenter stirrer speed was 500 rpm. inoculation was initiated with an aliquot (approximately 1 0.0 ml) of a fresh culture of the E.coli clone grown in Luria Broth with 100 μg/ml ampicillin at an OD 650 of 0.2 to 0.4. The cells were grown to an OD 650 of between 1 1 and 1 3 at 30°C, then they fed-batched with a medium concentrate, allowed to recover and grown to an OD 650 of between 14 and 1 6. They were subsequently induced by raising the temperature to 42°C. The cells were harvested 4 hours after maximum OD 650 was reached. The cells were recovered by hollow fibre filtration (0.1 μm, Amicon) and resuspended in 50 mM Tris-HCI (pH 8.0), 7.5 mM EDTA, 7.5 mM β- mercaptoethanol, 0.02% PMSF, 1 .0 μM pepstatin A, 0.02 % DNase and 0.02% iysozyme and incubated at 4°C for 1 hour (total volume of approximately 1 litre). The cells were sonicated on ice in 1 60 ml batches for 4 - 6 minutes in one minute blasts until lysed (monitored by microscopy) . An aliquot of 56 mM PMSF (in isopropanol) was added (each addition equivalent to 1 60 μM) for each two minutes of sonication to a final concentration of no more than 1 mM PMSF. After lysis was complete, cell debris was removed by centrifugation. The supernatant was heat treated at 70°C until obvious precipitation of protein occurred (usually about 20-30 minutes) and the denatured protein was removed by centrifugation. Prior to phenyl-sepharose chromatography, ammonium sulphate was added to the heat-treated supernatant to a final concentration of 1 .0 M (this is termed the 1 ° heat treatment extract) . The cell pellet derived from the sonicated cells was re- extracted by suspension in 1 .0 litre of 50 mM Tris-HCI (pH 8.0), 5 mM EDTA, 7 mM β-mercaptoethanol, followed by a second heat treatment at 70°C for 1 5 minutes and the precipitated protein was again removed by centrifugation. This was found to extract an additional 20 - 40% of the xylanase and was termed 2° heat treatment extract. Ammonium sulphate was added to this 2° heat treatment extract to 1 .0 M and the 1 ° and 2 ° heat treatment extracts were pooled prior to phenyl-sepharose separation. Xylanase activity was step- eluted from the 1 100 ml bed volume phenyl-sepharose column (after extensive washing with 1 .0 M ammonium sulphate and return to baseline) using 1 .0 M NaCI and the eluted protein was concentrated and desalted by ultrafiltration with a YM3 membrane (Amicon). The final concentration of the preparations are 25 mM Tris-HCI (pH 8.0), 5 mM EDTA, 7 mM β- mercaptoethanol, approximately 250 mM NaCI, 20% glycerol and 0.05% sodium azide. For production of the G-type xylanases the method was nearly identical to that described above except that HEPES buffer was used in place of TrisHCI for both the extraction (pH 8.0) and the desalting (pH 7.3) steps. The final preparation had a buffer composition of 50 mM HEPES, pH 7.3, 1 mM EDTA, 7 mM β-mercaptoethanol, 0.05% sodium Azide, 20.0% glycerol and ± 250 mM NaCI. In total 6 F-type preparations (5 xynA and 1 xynB) and 2 G-type preparation of sufficient purity were obtained. For both the F-type and the G- type preparation the protein concentration was determined by the standard BCA method (Pierce, Rockford, Illinois, USA). The purity of the samples was roughly estimated by running an SDS-PAGE gel (Phast-system, Pharmacia, 20 % gel) and comparing the thickness of the band at about 40 kDa for the F- type, and about 25 kDa for the G-type with the thickness of the bands of the impurities. The purity of the samples varied between 20 and 70% (Table 9). Table 9: Purity of F-type and G-type xylanase preparations Enzyme Purity (%) TG53xynA 30 TG53xynD (G-type) 20 TG456xynA 70 TG456xynD (G-type) 30 TG457xynA 70 TG479xynA 70 TG631 xynA 70 TG631 xynB 20 Example 1 2 ECF bleaching results with cloned F- and G-type xylanases ECF-bleaching was performed using oxygen delignified Kraft pulp from a Swedish pulp mill. The softwood (SW) pulp had a kappa number of 1 6.0 and the hardwood (HW) pulp a kappa number of 10.6. A XDED-sequence was used under conditions as presented in Table 10. Table 10: Bleaching conditions STAGE X Do E D, Cons 10 % 10 % 10 % 10 % Time 1 20 min 60 min 60 min 120 min. Temp 65°C 60°C 60°C 70°C pH 9 « 2.5 « 10 * 3.5 Chemical 1 5 μg xyl. chlorine mul¬ NaOH: aCI 2 : Dosage protein/ tiple: 0.1 5 7.2 kg/t 10 kg/t g Pulp (SW) (S/HW) 5.9 kg/t (HW) X = enzyme, C ) 0 ,D 1 = chlorine dioxide, E = ex1 traction with Na DH. The results of these experiments are presented in Table 1 1 . It can be seen that the G-type xylanases perform significantly better as compared with the F-type xylanases, when compared on the basis of enzyme protein. Table 1 1 : ECF bleaching with cloned F- and G-type xylanases. Enzyme Delta brightness (%ISO) SW HW TG53xynA 1 .0 21 1 .2 5 TG53xynD (G-type) 5.9 3) /6.8 4) 3.0 6) TG456xynA 1 .2 1 | .0.7 2 > 1 .0 5) TG456xynD (G-type) 4.3 3) /5.9 4 ' 4.0 5, /2.1 6) TG457xynA O 1 ' 0 6) TG479xynA 0.3 2 ' 0.3 5) TG631 xynA O 11 o 61 TG631 xynB 0 2) - refer to six separate experiments. The reference ISO brightness values of these experiments were as follows: expt 1 : 73.5; expt 2: 78.3; expt 3: 52.0; expt 4: 52.3; expt 5: 79.0; expt 6: 80.5. Example 1 3 ECF dose-response curves with cloned G-tvpe xylanases Using the same XDED bleaching sequence as described in Example 1 2 the dosage of the two G-type xylanases was varied. The results are shown in Table 1 2. Dosages of 1 to 3 μg/g pulp already give an increase in ISO brightness of at least two points. Table 1 2: Dose-response curves of two G-type xylanases Enzyme dosage Brightness HW Brightness SW (μg xyl (XDED) (XDED) • / g pulp) %ISO Δ %ISO %ISO Δ %ISO ' %ιso Δ %ISO TG456 xynD 0 78.5 - 55.85 - 62.92 - 1 80.73 2.23 56.80 0.95 65.73 2.81 3 81 .03 2.53 58.06 2.21 68.1 2 5.20 6 80.99 2.49 59.20 3.35 68.32 5.40 1 5 70.45 7.53 TG53 xynD 0 78.5 - 55.85 - 66.75 - 1 79.73 1.23 57.28 1 .43 69.04 2.29 3 80.1 3 1 .63 57.87 2.02 69.35 2.60 6 81 .32 2.82 58.23 2.38 69.92 3.1 7 1 5 72.39 5.64 Example 14 TCF bleaching results with cloned G-tvoe xylanases The two G-type xylanases were tested in a TCF bleaching sequence using the XQPP sequence as described in Example 1 5 (below) . Oxygen delignified hardwood kraftpulp was used (30 g o.d. per sample). The dosage of the G-type xylanases was varied as indicated in Table 1 3. ISO brightness values obtained for each sample after X, P1 and P2 stages are given in Table 1 3. The values represent the average of duplicate samples. Table 1 3: TCF bleaching - dose response experiment with G-type xylanases. Sample dosage X brightness P1 brightness P2 brightness ( g protein/ g- pulp) Control 0 50.3 79.5 81 .0 TG456 xynD 1 5 53.8 81.8 84.3 6 52.9 81 .0 83.8 TG53 xynD 1 5 55.2 82.2 85.1 6 53.6 82.7 85.1 The experiment was repeated using dosages of 3 and 6 μg protein per g pulp. Only the brightness values obtained after the P2 stage were determined. Results are presented in Table 14. Table 14. TCF bleaching - dose response experiment with G-type xylanases Sample dosage (μg P2 brightness protein/g pulp) Control 0 84.5 TG456 xynD 6 85.5 3 86.5 TG53 xynD 6 86.1 3 86.8 Example 15 ECF and TCF results, including paper properties Xylanase samples were tested for bleaching effect in ECF & TCF bleaching of a Kraft H/W and a Kraft S/W pulp supplied from a Swedish pulp mill. The cloned TG456 xynD and TG53 xynD (in this Example referred to as 71 5 and 71 6, respectively) are compared with "no-enzyme" reference samples. The refining tests in a Lampen ball mill showed that 71 5 gave the overall best performance with considerable improvements in Tear Index and no significant loss in Tensile and Burst Indices. Screening Protocol Hardwood Softwood 1. TCF Ref QPP 1. TCF Ref QPP 2. Enz715 XQPP 2. Enz715 XQPP 3. Enz716 XQPP 3. Enz716 XQPP 4. ECF Ref No X DEDED 4. ECF Ref No X DEDED 5. Enz715 XDEDED 5. Enz715 XDEDED 6. Enz716 XDEDED 6. Enz716 XDEDED 7. Chem Ref DEDED 7. Chem Ref DEDED Unbleached pulp properties Pulp Kappa No % ISO Bright¬ Viscosity ness dπrVkg Kraft H/W 10.8 53 1104 Kraft S/W 16.1 36.4 1003 Bleaching parameters to be tested TCF % ISO Chemical Kappa No Viscosity Paper Brightness consumption Strength After X XQP XQPP XQPP XQPP XQP XQPP XQPP ECF % ISO Chemical Kappa No Viscosity Paper Brightness consumption Strength After X XDE XDE XDEDED XDEDED XDE XDED XDED XDEDED XDEDED Bleaching conditions A) TCF H/W & S/W (Same bleaching conditions for both pulps) Stage X Q P P Consistency (%) 10 9 10 10 Time (mins) 1 20 5 *4 sees in 1 80 1 80 mixer Temp. (°C) 65 65 85 85 pH 9 4-5 10.5-1 1 10.5-1 1 Enz Charge 3 - - - EDTA Charge - 3 - - (kg/t) NaOH Charge - - 20 10 (kg/t) H 2 0 2 Charge - - 20 10 (kg/t) B) ECF H/W Stage X D E D ' E D Consistency 10 10 10 10 10 10 (%) Time (mins) 120 60 60 120 60 180 Temp PC) 65 60 60 70 60 70 pH 9 2-3 -11.5 2.5-3 -11.5 4-5 Enz Charge 3 - - - - - ( g/g) aCI Charge - 0.18* appa - 18 - 8 (kg/t) = 19.4 for X ref & all X's 21.6 for Chem Ref NaOH - - 11.6 for X - 10 - Charge ref & all (kg/t) X's 13 for Chem Ref C) ECF S/W Stage X D E D E D Consistency 10 10 10 10 10 10 (%) Time (mins) 120 60 60 120 60 180 Temp PC) 65 60 60 70 60 70 pH 9 2-3 -11.5 2.5-3 -11.5 4-5 Enz Charge 3 - - - - - (μg/g) aCI Charge - 0.18*Kap- - 18 - 8 (kg/t) pa = 28.8 for X ref & all X's 32 for Chem Ref NaOH - - 17.3 forX - 10 - Charge ref & all (kg/t) X's 19.2 for Chem Ref The results obtained in the above experiments are present in Tables 15 (Hardwood) and 16 (Softwood). Table 1 5: A summary of the Hardwood bleaching results Hardwood P2 % P2 P2 Vise Total P ISO Kappa TCF Ref 78.4 6.7 866 25.2 TCF 71 5 81 6.2 850 26.1 + +-- TCF 71 6 81 .7 6.2 740 27.7 + +- D2 % XDE D2 Vise Total aCI ISO Kappa ECF Ref 88.6 4.6 1050 46.1 ECF 71 5 89.1 4.5 1035 44.8 + +- + ECF 71 6 88.6 4.6 1040 45 00- + Chem Ref 88.6 4.9 1020 47 Table 1 6: A summary of the Softwood bleaching results. Softwood P2 % ISO P2 Kappa P2 Vise Total P TCF Ref 69.1 7.3 814 18.5 TCF 71 5 72.1 6.7 805 16 + +- + TCF 71 6 71 6.7 833 16.7 + + + D2 % ISO XDE D2 Vise Total Kappa aCI ECF Ref 85.5 4.6 941 54.5 ECF 71 5 86.5 4.4 935 54.4 + +-0 ECF 71 6 86.7 4.3 935 54.5 + +-0 Chem Ref 87.5 3.7 962 57.3 Verification of paper properties After all the sequences were fully bleached, 30 g samples were taken and refined in a Lampen ball mill for 10, 20 and 30 thousand revolutions. Schopper-Rieglers were measured, after which approximately 2 g sheets were made for Tensile Index, Porosity, Tear Index and Burst Index. The sheets were left to condition for 24 hours at 23 °C and 50% relative humidity. The results obtained are presented in Figures 4 to 8. Example 1 6 pH optimum, temperature optimum and thermostability of TG456 xynD Activities were measured as described in Example 2, procedure 1 , with oat spelt xylane as substrate. All assays were performed in 50 mM phosphate buffer, at the pH and temperature as indicated. The results are presented in Figures 9 and 10. The TG456 xylanase D is much more thermostable than the reference enzyme Pulpzyme HB (Novo Nordisk), and it has a slightly higher pH optimum. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: Gist-brocades B.V. (B) STREET: Wateringseweg 1 (C) CITY: Delft (E) COUNTRY: The Netherlands (F) POSTAL CODE (ZIP) : 2611 XT (ii) TITLE OF INVENTION: Thermostable xylanases (iii) NUMBER OF SEQUENCES: 13 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentin Release #1.0, Version #1.25 (EPO) (2) INFORMATION FOR SEQ ID NO: 1: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (C) INDIVIDUAL ISOLATE: xynFA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: CACACKCTKG TKTGGCA 17 (2) INFORMATION FOR SEQ ID NO: 2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (C) INDIVIDUAL ISOLATE: xynFB (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: CATAC TTKG TTTGGCA 17 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: YES (vi) ORIGINAL SOURCE: (C) INDIVIDUAL ISOLATE: xynR (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: TMGTT ACMA CRTCCCA 17 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (C) INDIVIDUAL ISOLATE: GF (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: TATNTGRSTN TMTATGGWTG G (2) INFORMATION FOR SEQ ID NO: 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: YES (vi) ORIGINAL .SOURCE: (C) INDIVIDUAL ISOLATE: GR (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5: CCGCTNCTTT GGTANCCTTC 20 (2) INFORMATION FOR SEQ ID NO: 6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1065 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Extremophile (C) INDIVIDUAL ISOLATE: TG456 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 3..1058 (D) OTHER INFORMATION: /product= "xylanase A" /gene= "xynA" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: CC ATG GAC CTT TAT TCA ATC TCA GAT GAA AAT TGG GGG CAG CCT GTG 47 Men Asp Leu Tyr Ser He Ser Asp Glu Asn Trp Gly Gin Pro Val 1 5 10 15 CCT GAT TAT AAA CTG CCA TCA CTT TGT GAA AAG TAC AAA AAC TAT TTC 95 Pro Asp Tyr Lys Leu Pro Ser Leu Cys Glu Lys Tyr Lys Asn Tyr Phe 20 25 30 AAG ATT GGA GTT GCT GTG CCC TAC AGG GCT CTG ACA AAT CCA GTT GAT 143 Lys He Gly Val Ala Val Pro Tyr Arg Ala Leu Thr Asn Pro Val Asp 35 40 45 GTG GAG ATG ATA AAA AGG CAT TTC AAC AGC ATA ACA CCG GAG AAC GAG 191 Val Glu Met He Lys Arg His Phe Asn Ser He Thr Pro Glu Asn Glu 50 55 60 ATG AAA CCA GAG AGC CTT CAG CCT TAT GAA GGT GGT TTT AGC TTT AGC 239 Met Lys Pro Glu Ser Leu Gin Pro Tyr Glu Gly Gly Phe Ser Phe Ser 65 70 75 ATT GCA GAT GAG TAT ATA GAT TTT TGC AAA AAG AAC AAT ATC TCA CTG 287 He Ala Asp Glu Tyr He Asp Phe Cys Lys Lys Asn Asn He Ser Leu 80 85 90 95 CGA GGG CAC ACK CTT GTT TGG CAT CAG CAA ACC CCG AGC TGG TTC TTT 335 Arg Gly His Thr Leu Val Trp His Gin Gin Thr Pro Ser Trp Phe Phe 100 105 110 ACA AAT CCT GAG ACG GGC GAA AAA CTT ACT AAC AGT GAG AAG GAC AAG 383 Thr Asn Pro Glu Thr Gly Glu Lys Leu Thr Asn Ser Glu Lys Asp Lys 115 120 125 RAA ATA CTA TTG GAT AGG CTA AAG AAG CAC ATC CAG ACA GTT GTT GGC 431 Xaa He Leu Leu Asp Arg Leu Lys Lys His He Gin Thr Val Val Gly 130 135 140 AGG TAT AAG GGG AAA GTA TAT GCA TGG GAC GTT GTG AAT GAG GCG ATT 479 Arg Tyr Lys Gly Lys Val Tyr Ala Trp Asp Val Val Asn Glu Ala He 145 150 155 GAT GAG AAT CAG CCG GAT GGG TAT AGA AGA AGT GAC TGG TAC AAT ATC 527 Asp Glu Asn Gin- Pro Asp Gly Tyr Arg Arg Ser Asp Trp Tyr Asn He 160 165 170 175 TTR GGA CCG GAG TAC ATT GAA AAG GCA TTT ATC TGG GCG CAT GAA GCA 575 Xaa Gly Pro Glu Tyr He Glu Lys Ala Phe He Trp Ala His Glu Ala 180 185 190 GAC CCG AAA GCA AAG CTT TTC TAC AAT GAC TAC AGT ACA GAA GAM CCA 623 Asp Pro Lys Ala Lys Leu Phe Tyr Asn Asp Tyr Ser Thr Glu Xaa Pro 195 200 205 TAT AAA AGA GGG AAT TTA TAT ACA CTA ATT AAA AAY TTA AAA GCM AAA 671 Tyr Lys Arg Gly Asn Leu Tyr Thr Leu He Lys Asn Leu Lys Ala Lys 210 215 220 GGT GTG CCA GTT CAT GGT GTT GGG CTT CAG TGT CAT ATT TCA CTT GAC 719 Gly Val Pro Val His Gly Val Gly Leu Gin Cys His He Ser Leu Asp 225 230 235 TGG CCG GAT GTG AGT GAA ATC GAG GAG ACT GTC AAA TTA TTT AGC AGG 767 Trp Pro Asp Val Ser Glu He Glu Glu Thr Val Lys Leu Phe Ser Arg 240 245 250 255 ATT CCA GGA CTT GAA ATA CAC TTC ACA GAA ATT GAT ATA AGT ATT GCT 815 He Pro Gly Leu Glu He His Phe Thr Glu He Asp He Ser He Ala 260 265 270 AAA AAC ATG ACC GAT GAT GAT GCA TAT AAC CGC TAT CTT TTG ATT CAG 863 Lys Asn Met Thr Asp Asp Asp Ala Tyr Asn Arg Tyr Leu Leu He Gin 275 280 285 CAG GCA CAA AAA TTA AAA GCA ATT TTT GAT GTT TTG AAA AAG TAC AGA 911 Gin Ala Gin Lys Leu Lys Ala He Phe Asp Val Leu Lys Lys Tyr Arg 290 295 300 AAT GTA GTT ACA AGT GTT ACA TTC TGG GGA CTG AAG GAT GAT TAC TCA 959 Asn Val Val Thr Ser Val Thr Phe Trp Gly Leu Lys Asp Asp Tyr Ser 305 310 315 TGG CTA CGG GGA GAT ATG CCA CTT TTA TTC GAT AAA GAC TAC CAG CCA 1007 Trp Leu Arg Gly Asp Met Pro Leu Leu Phe Asp Lys Asp Tyr Gin Pro 320 325 330 335 AAG TTT GCG TTC TGG AGC TTA ATT GAC CCA TCA GTT GTC CCA AAA GAG 1055 Lys Phe Ala Phe Trp Ser Leu He Asp Pro Ser Val Val Pro Lys Glu 340 345 350 TAATGGATCC 1065 (2) INFORMATION 'FOR SEQ ID NO: 7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 351 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7: Met Asp Leu Tyr Ser He Ser Asp Glu Asn Trp Gly Gin Pro Val Pro 1 5 10 15 Asp Tyr Lys Leu Pro Ser Leu Cys Glu Lys Tyr Lys Asn Tyr Phe Lys 20 25 30 He Gly Val Ala Val Pro Tyr Arg Ala Leu Thr Asn Pro Val Asp Val 35 40 45 Glu Met He Lys Arg His Phe Asn Ser He Thr Pro Glu Asn Glu Met 50 55 60 Lys Pro Glu Ser Leu Gin Pro Tyr Glu Gly Gly Phe Ser Phe Ser He 65 70 75 80 Ala Asp Glu Tyr He Asp Phe Cys Lys Lys Asn Asn He Ser Leu Arg 85 90 95 Gly His Thr Leu Val Trp His Gin Gin Thr Pro Ser Trp Phe Phe Thr 100 105 110 Asn Pro Glu Thr Gly Glu Lys Leu Thr Asn Ser Glu Lys Asp Lys Xaa 115 120 125 He Leu Leu Asp Arg Leu Lys Lys His He Gin Thr Val Val Gly Arg 130 135 140 Tyr Lys Gly Lys Val Tyr Ala Trp Asp Val Val Asn Glu Ala He Asp 145 150 155 160 Glu Asn Gin Pro Asp Gly Tyr Arg Arg Ser Asp Trp Tyr Asn He Xaa .165 170 175 Gly Pro Glu Tyr He Glu Lys Ala Phe He Trp Ala His Glu Ala Asp 180 185 190 Pro Lys Ala Lys Leu Phe Tyr Asn Asp Tyr Ser Thr Glu Xaa Pro Tyr 195 200 205 Lys Arg Gly Asn Leu Tyr Thr Leu He Lys Asn Leu Lys Ala Lys Gly 210 215 220 Val Pro Val His Gly Val Gly Leu Gin Cys His He Ser Leu Asp Trp 225 230 235 240 Pro Asp Val Ser Glu He Glu Glu Thr Val Lys Leu Phe Ser Arg He 245 250 255 Pro Gly Leu Glu He His Phe Thr Glu He Asp He Ser He Ala Lys 260 265 270 Asn Met Thr Asp Asp Asp Ala Tyr Asn Arg Tyr Leu Leu He Gin Gin 275 280 285 Ala Gin Lys Leu Lys Ala He Phe Asp Val Leu Lys Lys Tyr Arg Asn 290 295 300 Val Val Thr Ser Val Thr Phe Trp Gly Leu Lys Asp Asp Tyr Ser Trp 305 310 315 320 Leu Arg Gly Asp Met Pro Leu Leu Phe Asp Lys Asp Tyr Gin Pro Lys 325 330 335 Phe Ala Phe Trp Ser Leu He Asp Pro Ser Val Val Pro Lys Glu 340 345 350 (2) INFORMATION FOR SEQ ID NO: 8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1633 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Extremophile (C) INDIVIDUAL ISOLATE: TG456 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1632 (D) OTHER INFORMATION: /partial /product= "xylanase B" /gene= "xynB" (Xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: TGT ACC ATA AAA TGG CAG CAA ACA GTT CCA TCT GGG GTT TGG ACA GAA 48 Cys Thr He Lys Trp Gin Gin Thr Val Pro Ser Gly Val Trp Thr Glu 1 5 10 15 GTT TCT GGT TCA TAT ACA GTA CCA CAG ACA GCA ACC CAG CTC ATA TTC 96 Val Ser Gly Ser Tyr Thr Val Pro Gin Thr Ala Thr Gin Leu He Phe 20 25 30 TAT GTG GAA TCG CCA AAT GCA ACA CTT GAC TTT TAC CTT GAC GAC TTT 144 Tyr Val Glu Ser Pro Asn Ala Thr Leu Asp Phe Tyr Leu Asp Asp Phe 35 40 45 ACT GTA ATA GAC AAA AAC CCG GTT ACA ATA CCT GCT GCG GCA AAA GAG 192 Thr Val He Asp Lys Asn Pro Val Thr He Pro Ala Ala Ala Lys Glu 50 55 60 CCA GAG TTG GAG ATT CCA TCA CTT TGC CAG CAA TAC AGC CAG TAC TTT 240 Pro Glu Leu Glu He Pro Ser Leu Cys Gin Gin Tyr Ser Gin Tyr Phe 65 70 75 80 TCA ATT GGT GTT GCA ATA CCA TAT AGA GTG CTC CAA AAC CCG GTA GAA 288 Ser He Gly Val Ala He Pro Tyr Arg Val Leu Gin Asn Pro Val Glu 85 90 95 AGA GCA ATG GTT TTA AAG CAT TTC AAC AGT ATT ACT GCT GAA AAT GAG 336 Arg Ala Met Val Leu Lys His Phe Asn Ser He Thr Ala Glu Asn Glu 100 105 110 ATG AAG CCC GAT GCT ATA CAA AGA ACA GAA GGG CAG TTC AAT TTC GAT 384 Met Lys Pro Asp Ala He Gin Arg Thr Glu Gly Gin Phe Asn Phe Asp 115 120 125 GTT GCA GAC CAG TAT GTT GAC TTT GCA CAG AGC AAT AAT ATT GGA ATA 432 Val Ala Asp Gin Tyr Val Asp Phe Ala Gin Ser Asn Asn He Gly He 130 135 140 AGA GGT CAT ACA CTG GTT TGG CAT CAA CAA ACT CCA GAT TGG TTT TTC 480 Arg Gly His Thr Leu Val Trp His Gin Gin Thr Pro Asp Trp Phe Phe 145 150 155 160 CAG CAT TCT GAC GGT TCG CCA CTT GAT CCA AAC AAT TCT GAA GAC AAG 528 Gin His Ser Asp Gly Ser Pro Leu Asp Pro Asn Asn Ser Glu Asp Lys 165 170 175 CAG CTT TTG AGA AAT AGG TTA AAA ACA CAC ATT CAG ACA CTT GTT GGA 576 Gin Leu Leu Arg Asn Arg Leu Lys Thr His He Gin Thr Leu Val Gly 180 185 190 ■ I AGA TAT GCA GAG AAA GTT TAT GCA TGG GAT GTT GTA AAT GAA GCA ATT 624 Arg Tyr Ala Glu Lys Val Tyr Ala Trp Asp Val Val Asn Glu Ala He 195 200 205 GAT GAA AAT CAA CCG GAT GGA TAT AGA AGA AGT GAA TGG TAC AGA ATT 672 Asp Glu Asn Gin Pro Asp Gly Tyr Arg Arg Ser Glu Trp Tyr Arg He 210 215 220 TTA GGA CCA ACT CCA GAA ACA GGC GGA ATA CCA GAG TAT ATA ATC CTT 720 Leu Gly Pro Thr Pro Glu Thr Gly Gly He Pro Glu Tyr He He Leu 225 230 235 240 GCA TTC CAG TAT GCA CGG GAA GCT GAC CCG AAC GCA AAA CTT TTC TAC 768 Ala Phe Gin Tyr Ala Arg Glu Ala Asp Pro Asn Ala Lys Leu Phe Tyr 245 250 255 AAC GAT TAC AGC ACT GAA AAT CCA AAG AAG AGA CAG TTT ATT TAC AAC 816 Asn Asp Tyr Ser Thr Glu Asn Pro Lys Lys Arg Gin Phe He Tyr Asn 260 265 270 ATG GTC AAA GCT TTG CAT GAT AGA GGT CTC ATT GAT GGT GTT GGT CTG 864 Met Val Lys Ala Leu His Asp Arg Gly Leu He Asp Gly Val Gly Leu 275 280 285 CAG GGA CAT ATT AAT GTG GAT TCG CCT GCA GTC AAA GAA ATA GAA GAT 912 Gin Gly His He Asn Val Asp Ser Pro Ala Val Lys Glu He Glu Asp 290 295 300 ACA ATC AAT TTA TTC AGC ACA ATA CCG GGT CTT CAA ATT CAA ATA ACA 960 Thr He Asn Leu Phe Ser Thr He Pro Gly Leu Gin He Gin He Thr 305 310 ' 315 320 GAG CTT GAT ATC AGC GTA TAT ACA AGC AGC ACT CAG CAA TAT GAC ACA 1008 Glu Leu Asp He Ser Val Tyr Thr Ser Ser Thr Gin Gin Tyr Asp Thr 325 330 335 TTA CCA CAG GAT ATT ATG ATT AAA CAG GCT TTA AAA TTC AAA GAG CTG " 1056 Leu Pro Gin Asp He Met He Lys Gin Ala Leu Lys Phe Lys Glu Leu 340 345 350 TTT GAA ATG TTA AAG CGC CAC AGC GAC AGA ATC ACA AAT GTT ACA CTT 1104 Phe Glu Met Leu Lys Arg His Ser Asp Arg He Thr Asn Val Thr Leu 355 360 365 TGG GGT CTC AAA GAT GAT TAT CCA TGG CTG TCA AAA GAT AGA AGT AAC 1152 Trp Gly Leu Lys Asp Asp Tyr Pro Trp Leu Ser Lys Asp Arg Ser Asn 370 375 380 TGG CCA CTG CTA TTT GAT AGT AAC TAC CAG GCA AAA TAC AAT TAC TGG 1200 Trp Pro Leu Leu Phe Asp Ser Asn Tyr Gin Ala Lys Tyr Asn Tyr Trp 385 390 395 400 GCT ATT GTA GAA CCT TCG GTG TTG CCT GTT GCT ATA AAT AAG GGA TAT 1248 Ala He Val Glu Pro Ser Val Leu Pro Val Ala He Asn Lys Gly Tyr 405 410 415 GCG AAC AAT GCA CAG CCA AGA ATT GAT GGG ATT ATG GAT AAA GAA TAC 1296 Ala Asn Asn Ala Gin Pro Arg He Asp Gly He Met Asp Lys Glu Tyr 420 425 430 AAA GGA ACC ATT CCA CTT TCG GTT TTG AAT GAT GCA GGG CAG GAT ATT 1344 Lys Gly Thr He Pro Leu Ser Val Leu Asn Asp Ala Gly Gin Asp He 435 440 445 GCT CAG GTA AGG GCA CTG TGG AGT GGC AAT GAG CTT TGT CTT TAT GTC 1392 Ala Gin Val Arg Ala Leu Trp Ser Gly Asn Glu Leu Cys Leu Tyr Val 450 455 460 ACT GTA AAT GAT TCA AGT GTG GAT GCT AAC AAT GAT AGG GTT GTA ATT 1440 Thr Val Asn Asp Ser Ser Val Asp Ala Asn Asn Asp Arg Val Val He 465 470 475 480 TTC ATT GAT CAG GAC AAT GGA AAG TTG CCA GAG TTA AAA GAT GAT GAC 1488 Phe He Asp Gin Asp Asn Gly Lys Leu Pro Glu Leu Lys Asp Asp Asp 485 490 495 TTC TGG GTT TCA ATT TCG AGA AAT GGC ACA AAG AAT CAA TCC AAA ACT 1536 Phe Trp Val Ser He Ser Arg Asn Gly Thr Lys Asn Gin Ser Lys Thr 500 505 510 GGC TAT GTA AAA GAT TAT GTA GTG TTA CAG CAA TTA AAT GGA TAT ACA 1584 Gly Tyr Val Lys Asp Tyr Val Val Leu Gin Gin Leu Asn Gly Tyr Thr 515 520 525 ATG GAG GTT AAG CTG CTT TTA AAC AAC AGT TTA GCA ATT AAC ACA AAT 1632 Met Glu Val Lys Leu Leu Leu Asn Asn Ser Leu Ala He Asn Thr Asn 530 535 540 A 1633 (2) INFORMATION FOR SEQ ID NO: 9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 544 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9: Cys Thr He Lys Trp Gin Gin Thr Val Pro Ser Gly Val Trp Thr Glu 1 5 10 15 Val Ser Gly Ser Tyr Thr Val Pro Gin Thr Ala Thr Gin Leu He Phe 20 25 30 Tyr Val Glu Ser Pro Asn Ala Thr Leu Asp Phe Tyr Leu Asp Asp Phe 35 40 45 Thr Val He Asp Lys Asn Pro Val Thr He Pro Ala Ala Ala Lys Glu 50 55 60 Pro Glu Leu Glu He Pro Ser Leu Cys Gin Gin Tyr Ser Gin Tyr Phe 65 70 75 80 Ser He Gly Val Ala He Pro Tyr Arg Val Leu Gin Asn Pro Val Glu 85 90 95 Arg Ala Met Val Leu Lys His Phe Asn Ser He Thr Ala Glu Asn Glu 100 105 110 Met Lys Pro Asp Ala He Gin Arg Thr Glu Gly Gin Phe Asn Phe Asp 115 120 125 Val Ala Asp Gin Tyr Val Asp Phe Ala Gin Ser Asn Asn He Gly He 130 135 140 Arg Gly His Thr Leu Val Trp His Gin Gin Thr Pro Asp Trp Phe Phe 145 150 155 160 Gin His Ser Asp Gly Ser Pro Leu Asp Pro Asn Asn Ser Glu Asp Lys 165 170 175 Gin Leu Leu Arg Asn Arg Leu Lys Thr His He Gin Thr Leu Val Gly 180 185 190 Arg Tyr Ala Glu Lys Val Tyr Ala Trp Asp Val Val Asn Glu Ala He 195 200 205 Asp Glu Asn Gin Pro Asp Gly Tyr Arg Arg Ser Glu Trp Tyr Arg He 210 215 220 Leu Gly Pro Thr Pro Glu Thr Gly Gly He Pro Glu Tyr He He Leu 225 230 235 240 Ala Phe Gin Tyr Ala Arg Glu Ala Asp Pro Asn Ala Lys Leu Phe Tyr 245 250 255 Asn Asp Tyr Ser Thr Glu Asn Pro Lys Lys Arg Gin Phe He Tyr Asn 260 265 270 Met Val Lys Ala Leu His Asp Arg Gly Leu He Asp Gly Val Gly Leu 275 280 285 Gin Gly His He Asn Val Asp Ser Pro Ala Val Lys Glu He Glu Asp 290 295 300 Thr He Asn Leu Phe Ser Thr He Pro Gly Leu Gin He Gin He Thr 305 310 315 320 Glu Leu Asp He Ser Val Tyr Thr Ser Ser Thr Gin Gin Tyr Asp Thr 325 330 335 Leu Pro Gin Asp He Met He Lys Gin Ala Leu Lys Phe Lys Glu Leu 340 345 350 Phe Glu Met Leu Lys Arg His Ser Asp Arg He Thr Asn Val Thr Leu 355 360 365 Trp Gly Leu Lys Asp Asp Tyr Pro Trp Leu Ser Lys Asp Arg Ser Asn 370 375 380 Trp Pro Leu Leu Phe Asp Ser Asn Tyr Gin Ala Lys Tyr Asn Tyr Trp 385 390 395 400 Ala He Val Glu Pro Ser Val Leu Pro Val Ala He Asn Lys Gly Tyr 405 410 415 Ala Asn Asn Ala Gin Pro Arg He Asp Gly He Met Asp Lys Glu Tyr 420 425 430 Lys Gly Thr He Pro Leu Ser Val Leu Asn Asp Ala Gly Gin Asp He 435 440 445 Ala Gin Val Arg Ala Leu Trp Ser Gly Asn Glu Leu Cys Leu Tyr Val 450 455 460 Thr Val Asn Asp Ser Ser Val Asp Ala Asn Asn Asp Arg Val Val He 465 470 475 480 Phe He Asp Gin Asp Asn Gly Lys Leu Pro Glu Leu Lys Asp Asp Asp 485 490 495 Phe Trp Val Ser He Ser Arg Asn Gly Thr Lys Asn Gin Ser Lys Thr 500 505 510 Gly Tyr Val Lys Asp Tyr Val Val Leu Gin Gin Leu Asn Gly Tyr Thr 515 520 525 Met Glu Val Lys Leu Leu Leu Asn Asn Ser Leu Ala He Asn Thr Asn 530 535 540 (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1125 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Extremophile (C) INDIVIDUAL ISOLATE: TG456 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1125 (D) OTHER INFORMATION: /partial /product= "xylanase C" /gene= "xynC" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: CGC GAG TTA TTA CTT TAT GTT GAG GCG CAA AAT GCA AAT TTG GCT TTC 48 Arg Glu Leu Leu Leu Tyr Val Glu Ala Gin Asn Ala Asn Leu Ala Phe 1 5 10 15 TGG GTT GAT GAT TTA AAG ATT TAT GAT TTA TCC AAG CTG GCT GAA CCT 96 Trp Val Asp Asp Leu Lys He Tyr Asp Leu Ser Lys Leu Ala Glu Pro 20 25 30 GAA TGG GAG ATA CCA TCT TTG ATA GAA AAG TAT AAA GAT TAT TTC AAA 144 Glu Trp Glu He Pro Ser Leu He Glu Lys Tyr Lys Asp Tyr Phe Lys 35 40 45 GTA GGG GTA GCT TTG TCT TAC AAA AGC ATT GCT YCT GAT ACA GAG AAG 192 Val Gly Val Ala Leu Ser Tyr Lys Ser He Ala Xaa Asp Thr Glu Lys 50 55 60 AAG ATG GTT TTG AAG CAT TTC AAT AGT ATT ACT GCA GGG AAT GAA ATG 240 Lys Met Val Leu Lys His Phe Asn Ser He Thr Ala Gly Asn Glu Met 65 70 75 80 AAA CCA TCA GAG TTA CTT ATC AGT GAA AAT AAT TAT AAC TTT AGT AAA 288 Lys Pro Ser Glu -Leu Leu He Ser Glu Asn Asn Tyr Asn Phe Ser Lys 85 90 95 GCA GAT GAA TTT GTA AAT TTT GCA ACA AGT AAC AAC ATT GCC ATC AGA 336 Ala Asp Glu Phe Val Asn Phe Ala Thr Ser Asn Asn He Ala He Arg 100 105 110 GGT CAT ACA CTG GTT TGG CAT GAG CAA ACA CCC GAC TGG TTT TTC AAG 384 Gly His Thr Leu Val Trp His Glu Gin Thr Pro Asp Trp Phe Phe Lys 115 120 125 GAT GCA AAT GGA AAT ACC TTG AGC AAG GAT GCA TTG CTA AGC AGA TTA 432 Asp Ala Asn Gly Asn Thr Leu Ser Lys Asp Ala Leu Leu Ser Arg Leu 130 135 140 AAG CAG TAT ATT TAT ACG GTA GTG GGA AGA TAT AAA GGG AAG GTT TAT 480 Lys Gin Tyr He Tyr Thr Val Val Gly Arg Tyr Lys Gly Lys Val Tyr 145 150 155 160 GCA TGG GAT GTG GTA AAT RAA GCA ATA GAT GAA AGT CAA GGT AAT GGA '528 Ala Trp Asp Val Val Asn Xaa Ala He Asp Glu Ser Gin Gly Asn Gly 165 170 175 TTC AGG AGA TCT AAC TGG TAC AAC ATT TGT GGT CCC GAA TAT ATT GAA 576 Phe Arg Arg Ser Asn Trp Tyr Asn He Cys Gly Pro Glu Tyr He Glu 180 185 190 AAG GCT TTT ATA TGG GCA CAT GAR GCC GAT CCA GAC GCA AAA TTG TTT 624 Lys Ala Phe He Trp Ala His Glu Ala Asp Pro Asp Ala Lys Leu Phe 195 200 205 TAC AAC GAT TAC AAC ACA GAA AAC AGT CAG AAG AGA CAG TTT ATT TMC 672 Tyr Asn Asp Tyr Asn Thr Glu Asn Ser Gin Lys Arg Gin Phe He Xaa 210 215 220 AAC ATG ATT AAG AGT CTC AAG GAA AAA GGT GTT CCA ATT CAT GGA ATA 720 Asn Met He Lys Ser Leu Lys Glu Lys Gly Val Pro He His Gly He 225 230 235 240 GGA TTG CGG TGT CAT ATA AAT CTT GAT TGG CCC TCG ATT AGC GAG ATA 768 Gly Leu Arg Cys His He Asn Leu Asp Trp Pro Ser He Ser Glu He 245 250 255 GAG AAC ACC ATA AAA TTG TTC AGC TCT ATA CCT GGA TTG GAG ATA CAC 816 Glu Asn Thr He Lys Leu Phe Ser Ser He Pro Gly Leu Glu He His 260 265 270 ATT ACG GAG CTT GAT ATG AGT TTT TAT CAG TGG GGT TCG AGT ACC AGT 864 He Thr Glu Leu Asp Met Ser Phe Tyr Gin Trp Gly Ser Ser Thr Ser 275 280 285 TAT TCA ACG CCA CCM AGA GAT CTC CTG ATA AAA CAG GCA ATG AGA TAT 912 Tyr Ser Thr Pro Pro Arg Asp Leu Leu He Lys Gin Ala Met Arg Tyr 290 295 300 AAG GAG TTA TTC GAT TTA TTT AAA AAG TAC AAT GTA ATA ACT AAT GTA 960 Lys Glu Leu Phe Asp Leu Phe Lys Lys Tyr Asn Val He Thr Asn Val 305 310 315 320 ACA TTC TGG GGA CTA AAG GAT GAT TAC TCA TGG CTG AGT CAA AAC TTT 1008 Thr Phe Trp Gly Leu Lys Asp Asp Tyr Ser Trp Leu Ser Gin Asn Phe 325 330 335 GGA AAA AGT GAT TAC CCG TTG TTA TTT GAT GGA AAC TAT AAG TCA AAA 1056 Gly Lys Ser Asp Tyr Pro Leu Leu Phe Asp Gly Asn Tyr Lys Ser Lys 340 345 350 TAT GCC TTT TGG AGC CTG ATT GAG CCA ACT GTG GTG CCG GTT ACC GGT 1104 Tyr Ala Phe Trp Ser Leu He Glu Pro Thr Val Val Pro Val Thr Gly 355 360 365 CAT AGC TGT TTT TGC GCC ATG 1125 His Ser Cys Phe Cys Ala Met 370 375 (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 375 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11: Arg Glu Leu Leu Leu Tyr Val Glu Ala Gin Asn Ala Asn Leu Ala Phe 1 5 10 15 Trp Val Asp Asp Leu Lys He Tyr Asp Leu Ser Lys Leu Ala Glu Pro 20 25 30 Glu Trp Glu He Pro Ser Leu He Glu Lys Tyr Lys Asp Tyr Phe Lys 35 40 45 Val Gly Val Ala Leu Ser Tyr Lys Ser He Ala Xaa Asp Thr Glu Lys 50 55 60 Lys Met Val Leu Lys His Phe Asn Ser He Thr Ala Gly Asn Glu Met 65 70 75 80 Lys Pro Ser Glu"Leu Leu He Ser Glu Asn Asn Tyr Asn Phe Ser Lys 85 90 95 Ala Asp Glu Phe Val Asn Phe Ala Thr Ser Asn Asn He Ala He Arg 100 105 110 Gly His Thr Leu Val Trp His Glu Gin Thr Pro Asp Trp Phe Phe Lys 115 120 125 Asp Ala Asn Gly Asn Thr Leu Ser Lys Asp Ala Leu Leu Ser Arg Leu 130 135 140 Lys Gin Tyr He Tyr Thr Val Val Gly Arg Tyr Lys Gly Lys Val Tyr 145 150 155 160 Ala Trp Asp Val Val Asn Xaa Ala He Asp Glu Ser Gin Gly Asn Gly 165 170 175 Phe Arg Arg Ser Asn Trp Tyr Asn He Cys Gly Pro Glu Tyr He Glu 180 185 190 Lys Ala Phe He Trp Ala His Glu Ala Asp Pro Asp Ala Lys Leu Phe 195 200 205 Tyr Asn Asp Tyr Asn Thr Glu Asn Ser Gin Lys Arg Gin Phe He Xaa 210 215 220 Asn Met He Lys Ser Leu Lys Glu Lys Gly Val Pro He His Gly He 225 230 235 240 Gly Leu Arg Cys His He Asn Leu Asp Trp Pro Ser He Ser Glu He 245 250 255 Glu Asn Thr He Lys Leu Phe Ser Ser He Pro Gly Leu Glu He His 260 265 270 He Thr Glu Leu Asp Met Ser Phe Tyr Gin Trp Gly Ser Ser Thr Ser 275 280 285 Tyr Ser Thr Pro Pro Arg Asp Leu Leu He Lys Gin Ala Met Arg Tyr 290 295 300 Lys Glu Leu Phe Asp Leu Phe Lys Lys Tyr Asn Val He Thr Asn Val 305 310 315 320 Thr Phe Trp Gly Leu Lys Asp Asp Tyr Ser Trp Leu Ser Gin Asn Phe 325 330 335 Gly Lys Ser Asp Tyr Pro Leu Leu Phe Asp Gly Asn Tyr Lys Ser Lys 340 345 350 Tyr Ala Phe Trp Ser Leu He Glu Pro Thr Val Val Pro Val Thr Gly 355 360 365 His Ser Cys Phe Cys Ala Met 370 375 (2) INFORMATION FOR SEQ ID NO: 12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1244 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Extremophi1e (C) INDIVIDUAL ISOLATE: TG456 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1107 (D) OTHER INFORMATION: /partial /product= "xylanase D" /gene= "xynD" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: AAA GTC TTG CTG GCT GCT CTG ATG TGT GTT GTG TTG GCT AAT CCT TTT 48 Lys Val Leu Leu Ala Ala Leu Met Cys Val Val Leu Ala Asn Pro Phe 1 5 10 15 TAT GCA CAG GCA GCC ATG ACA TTT ACC TCT AAT GCA ACT GGG ACA TAC 96 Tyr Ala Gin Ala Ala Met Thr Phe Thr Ser Asn Ala Thr Gly Thr Tyr 20 25 30 GAT GGT TAC TAC TAC GAG TTG TGG AAG GAC ACA GGG AAT ACT ACC ATG 144 Asp Gly Tyr Tyr Tyr Glu Leu Trp Lys Asp Thr Gly Asn Thr Thr Met 35 40 45 ACA GTT GAC ACA GGA GGA AGA TTT AGC TGT CAG TGG AGT AAC ATT AAC 192 Thr Val Asp Thr Gly Gly Arg Phe Ser Cys Gin Trp Ser Asn He Asn 50 55 60 AAT GCA CTC TTC AGA ACA GGT AAA AAG TTT AGC ACT GCA TGG AAT CAG 240 Asn Ala Leu Phe Arg Thr Gly Lys Lys Phe Ser Thr Ala Trp Asn Gin 65 70 75 80 CTT GGG ACT GTA AAG ATT ACC TAC TCT GCT ACC TAC AAT CCA AAT GGC 288 Leu Gly Thr Val Lys He Thr Tyr Ser Ala Thr Tyr Asn Pro Asn Gly 85 90 95 AAT TCC TAT CTC TGC ATT TAT GGA TGG TCA AGA AAT CCA CTT GTT GAA 336 Asn Ser Tyr Leu Cys He Tyr Gly Trp Ser Arg Asn Pro Leu Val Glu 100 105 110 TTT TAT ATC GTT GAA AGC TGG GGC TCA TGG CGT CCG CCC GGG GCA ACG 384 Phe Tyr He Val Glu Ser Trp Gly Ser Trp Arg Pro Pro Gly Ala Thr 115 120 125 TCA CTT GGC ACT GTA ACA ATT GAT GGA GCA ACA TAT GAT ATT TAT AAG 432 Ser Leu Gly Thr Val Thr He Asp Gly Ala Thr Tyr Asp He Tyr Lys 130 135 140 ACA ACT CGT GTT AAT CAG CCA TCT ATC GAA GGA ACA AGA ACA TTT GAT 480 Thr Thr Arg Val Asn Gin Pro Ser He Glu Gly Thr Arg Thr Phe Asp 145 150 155 160 CAG TAC TGG AGT GTT AGG ACA TCA AAG AGA ACA AGT GGT ACT GTT ACT 528 Gin Tyr Trp Ser Val Arg Thr Ser Lys Arg Thr Ser Gly Thr Val Thr 165 170 175 GTA ACT GAT CAT TTC AAA GCA TGG GCT GCA AAA GGT TTG AAC CTG GGT 576 Val Thr Asp His Phe Lys Ala Trp Ala Ala Lys Gly Leu Asn Leu Gly 180 185 190 ACA ATT GAC CAG ATT ACA CTC TGT GTG GAA GGY TAC CAR AGC AGC GGC 624 Thr He Asp Gin He Thr Leu Cys Val Glu Gly Tyr Gin Ser Ser Gly 195 200 205 TCA GCA AAT ATA ACA CAG AAT ACA TTT ACT ATT GGT GGT TCG AGT AGT 672 Ser Ala Asn He Thr Gin Asn Thr Phe Thr He Gly Gly Ser Ser Ser 210 215 220 GGC TCA AGT AAT GGT TCA AAT AAC GGT TCA AAT GAT GGT TCC AAT GGA 720 Gly Ser Ser Asn Gly Ser Asn Asn Gly Ser Asn Asp Gly Ser Asn Gly 225 230 235 240 GGA ACA AAT GCA GGA ATT TCA ACY GCA AGC AGG ATA GAA TGT GAA AGT 768 Gly Thr Asn Ala Gly He Ser Thr Ala Ser Arg He Glu Cys Glu Ser 245 250 255 ATG TCG CTC AGC GGY CCT TAT GTT TCA AGA ATT ACT TAT CCA TTT AAT 816 Met Ser Leu Ser Gly Pro Tyr Val Ser Arg He Thr Tyr Pro Phe Asn 260 265 270 GGT ATA GCA CTT TAT GCG AAC GGA GAT AGA GCA ACG GCA AAT GTA AAC 864 Gly He Ala Leu Tyr Ala Asn Gly Asp Arg Ala Thr Ala Asn(Val Asn 275 280 285 TTT TCA GCA AGC CGT AAC TAT ACT TTT AAA TTA CGT GGA TGT GGA AAT 912 Phe Ser Ala Ser Arg Asn Tyr Thr Phe Lys Leu Arg Gly Cys Gly Asn 290 295 300 AAC AAT AAT TTG GCA TCA GTT GAT TTA CTG ATA GAT GGA AAG AAA GTA 960 Asn Asn Asn Leu Ala Ser Val Asp Leu Leu He Asp Gly Lys Lys Val 305 310 315 320 GGT TCG TTC TAT TAT AAG GGA ACA TAT CCT TGG GAA GCY TCT ATA AAT 1008 Gly Ser Phe Tyr Tyr Lys Gly Thr Tyr Pro Trp Glu Ala Ser He Asn 325 330 335 AAT GTG TAT GTA AGT GCA GGT ACC CAC AGA GWG GAG CTT GTA CTT TCT 1056 Asn Val Tyr Val Ser Ala Gly Thr His Arg Xaa Glu Leu Val Leu Ser 340 345 350 GCT GAT AAT GGT ACA TGG GAT GTC TAT GCG GAT TAT TTG TTA ATA CAA 1104 Ala Asp Asn Gly Thr Trp Asp Val Tyr Ala Asp Tyr Leu Leu He Gin 355 360 365 TGAAATTCGG AAATGTTTTT AAAAATACTG CTTCGRAGAA GCAGGTATTT TTTTATGTTC 1164 ACTATTATAA AGCGATTGAA GTCAGTCTTA GTTCATCCTA GTTGTTCTTC ARACCGRTCA 1224 TAGCTGTTTC CKGCGCCATG 1244 (2) INFORMATION FOR SEQ ID NO: 13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 368 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: Lys Val Leu Leu Ala Ala Leu Met Cys Val Val Leu Ala Asn Pro Phe 1 5 10 15 Tyr Ala Gin Ala Ala Met Thr Phe Thr Ser Asn Ala Thr Gly Thr Tyr 20 25 30 Asp Gly Tyr Tyr Tyr Glu Leu Trp Lys Asp Thr Gly Asn Thr Thr Met 35 40 45 Thr Val Asp Thr Gly Gly Arg Phe Ser Cys Gin Trp Ser Asn He Asn 50 55 60 Asn Ala Leu Phe Arg Thr Gly Lys Lys Phe Ser Thr Ala Trp Asn Gin 65 70 75 80 Leu Gly Thr Val Lys He Thr Tyr Ser Ala Thr Tyr Asn Pro Asn Gly 85 90 95 Asn Ser Tyr Leu Cys He Tyr Gly Trp Ser Arg Asn Pro Leu Val Glu 100 105 110 Phe Tyr He Val Glu Ser Trp Gly Ser Trp Arg Pro Pro Gly Ala Thr 115 120 125 Ser Leu Gly Thr Val Thr He Asp Gly Ala Thr Tyr Asp He Tyr Lys 130 135 140 Thr Thr Arg Val Asn Gin Pro Ser He Glu Gly Thr Arg Thr Phe Asp 145 150 155 160 Gin Tyr Trp Ser Val Arg Thr Ser Lys Arg Thr Ser Gly Thr Val Thr 165 170 175 Val Thr Asp His Phe Lys Ala Trp Ala Ala Lys Gly Leu Asn Leu Gly 180 185 190 Thr He Asp Gin He Thr Leu Cys Val Glu Gly Tyr Gin Ser Ser Gly 195 200 205 Ser Ala Asn He Thr Gin Asn Thr Phe Thr He Gly Gly Ser Ser Ser 210 215 220 Gly Ser Ser Asn Gly Ser Asn Asn Gly Ser Asn Asp Gly Ser Asn Gly 225 230 235 240 Gly Thr Asn Ala Gly He Ser Thr Ala Ser Arg He Glu Cys Glu Ser 245 250 255 Met Ser Leu Ser Gly Pro Tyr Val Ser Arg He Thr Tyr Pro Phe Asn 260 265 270 Gly He Ala Leu Tyr Ala Asn Gly Asp Arg Ala Thr Ala Asn Val Asn 275 280 285 Phe Ser Ala Ser Arg Asn Tyr Thr Phe Lys Leu Arg Gly Cys Gly Asn 290 295 300 Asn Asn Asn Leu Ala Ser Val Asp Leu Leu He Asp Gly Lys Lys Val 305 310 315 320 Gly Ser Phe Tyr Tyr Lys Gly Thr Tyr Pro Trp Glu Ala Ser He Asn 325 330 335 ! Asn Val Tyr Val Ser Ala Gly Thr His Arg Xaa Glu Leu Val Leu Ser 340 345 350 Ala Asp Asn Gly Thr Trp Asp Val Tyr Ala Asp Tyr Leu Leu He Gin 355 360 365

Claims: Claims 1 . A xylanase characterized in that it has a significant delignifying activity at a temperature of 80°C or higher. 2. A xylanase according to claim 1 with a half-life at 80°C and pH 9.0 of more than 1 0 minutes. 3. A xylanase according to claim 1 characterized in that: a) the xylanase is a G-type xylanase, and b) the xylanase is derived from a thermophilic organism with an optimum growth temperature in excess of 65 °C. 4. A xylanase according to claim 3 characterized in that the thermophilic organism is anaerobic. 5. A xylanase according to claim 3 characterized in that its amino acid sequence shares at least 70 % identity with the amino acid sequence of SEQ ID NO 1 3. 6. A xylanase according to claim 3 characterized in that the xylanase has a half-life at 80°C and at pH 7.0 of more than 10 minutes. 7. A xylanase according to claim 3 characterized in that the xylanase has an half-life at 65 °C and at pH 9.0 of more than 10 minutes. 8. A xylanase according to any one of the previous claims characterized in that the xylanase is derived from a strain selected from the group consisting of the strains deposited under the following deposition numbers: CBS 21 1 .94, 212.94, 21 3.94, 214.94, 21 5.94, and 21 6.94. 9. An isolated and purified DNA sequence characterized in that it encodes at least a part of the xylanases according to any one of the previous claims. 1 0. A vector characterized in that it contains the DNA sequence of claim 9. 1 1 . A microbial host cell characterized in that it is transformed with the vector of claim 1 0. 1 2. An isolated microorganism characterized as an anaerobic and thermophilic bacterium and having deposition number CBS 21 1 .94, 21 2.94, 21 3.94, 214.94, 21 5.94, or 21 6.94. 1 3. A process for the preparation of a xylanase characterized in that the xylanase is obtainable by cultivation of any one of the deposited microorganisms of claim 1 2 or by cultivation of a transformed host cell according to claim 1 1 in a suitable medium, followed by recovery of the enzymes having the indicated activity. 14. A process for degradation of xylan comprising the use of a xylanase obtained according to the process as defined in claim 1 3. 1 5. A process according to claim 1 4 wherein the xylanase is used at a temperature of 80°C or higher. 1 6. A process for delignifying wood pulp characterized in that a xylanase is used at a temperature of 80°C or higher. 17. A process for delignifying wood pulp comprising the use of a xylanase obtained according to the process as defined in claim 13. 1 8. A process according to claim 1 6 wherein the xylanase is used at a temperature of 80°C or higher. 1 9. A process according to any one of the claims 1 6 to 1 8 further characterized in that the xylanase is used before or during the oxygen delignification step. 20. A product obtained after the treatment of wood pulp using a process according to any one of the claims 1 6 to 1 9.

Inventors: BERGQUIST PETER LEONARD, DANIEL ROY MCIVER, FARREL ROBERTA LEE, FORSTER SIMON, GROENBERG VIDAR, HERWEIJER MARGARETA ADRIANA, IVERSON SARA, JONES BRIAN EDWARD, MOODY DEAN, MORGAN HUGH WILLIAM, QUAX WILHELMUS JOHANNES, WILLIAMS DIANE P, BERGQUIST, PETER, LEONARD, DANIEL, ROY, MCIVER, FARREL, ROBERTA, LEE, FORSTER, SIMON, GROENBERG, VIDAR, HERWEIJER, MARGARETA, ADRIANA, IVERSON, SARA, JONES, BRIAN, EDWARD, MOODY, DEAN, MORGAN, HUGH, WILLIAM, QUAX, WILHELMUS, JOHANNES, WILLIAMS, DIANE, P.
Applicants: BERGQUIST PETER LEONARD, DANIEL ROY MCIVER, FARREL ROBERTA LEE, FORSTER SIMON, GIST BROCADES BV, GROENBERG VIDAR, HERWEIJER MARGARETA ADRIANA, IVERSON SARA, JONES BRIAN EDWARD, MOODY DEAN, MORGAN HUGH WILLIAM, QUAX WILHELMUS JOHANNES, WILLIAMS DIANE P, BERGQUIST, PETER, LEONARD, DANIEL, ROY, MCIVER, FARREL, ROBERTA, LEE, FORSTER, SIMON, GIST-BROCADES B.V., GROENBERG, VIDAR, HERWEIJER, MARGARETA, ADRIANA, IVERSON, SARA, JONES, BRIAN, EDWARD, MOODY, DEAN, MORGAN, HUGH, WILLIAM, QUAX, WILHELMUS, JOHANNES, WILLIAMS, DIANE, P.
Application year: 1995
Main classification: C12N15
IPC codes: C12N1, C12N9, C12N15, C12S3, D21C5, D21C9